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Samenvatting 
 
Aviaire pathogene Escherichia coli (APEC) veroorzaakt jaarlijks grote economische schade 
voor de pluimveesector als gevolg van sterfte, een tragere groei, een lagere 
voederomzettingsefficiëntie en afkeuring van karkassen in het slachthuis. Inhalatie van stof 
verontreinigd met hoge concentraties Escherichia coli kan de luchtzakken en longen 
infecteren, waarna de bacteriën de bloedbaan kunnen binnendringen met als gevolg een 
systemische infectie (bekend als colibacillose). 
De ziekte wordt traditioneel behandeld met antibiotica, maar door veelvuldig gebruik van 
antibiotica zijn vele APEC stammen multiresistent geworden. Het gebruik van antibiotica 
veroorzaakt een risico voor de volksgezondheid, als gevolg van de overdracht van 
resistentiegenen/resistente bacteriën van dier op mens. Daarom werd gedurende dit onderzoek 
het gebruik van desinfectantia en bacteriofaagtherapie getest als alternatieve preventie/ 
behandelingsmethode voor colibacillose bij kippen. 
Eerst werd de antibioticaresistentie van een selectie APEC stammen (n = 97) bepaald, 
representatief voor de Belgische leghennen industrie, aangezien er minder kennis is over 
APEC isolaten van legkippen dan isolaten van vleeskuikens. Verder werd bepaald of deze 
APEC isolaten resistent waren tegen de meest voorkomende werkzame stoffen (formaldehyde, 
glutaaraldehyde, glyoxaal, waterstofperoxide (H2O2) en een quaternaire ammoniumverbinding 
(QAC)) in routinematig gebruikte ontsmettingsmiddelen in de pluimvee-industrie. De 
biofilmvorming capaciteit van de stammen op materialen die veelvuldig in kippenstallen 
gebruikt worden werd bepaald, aangezien biofilmvorming een effect op de efficaciteit van 
desinfectantia kan hebben. Hoge resistentiepercentages tegen routinematig gebruikte 
antibiotica in de pluimveesector (ampicilline, nalidixinezuur, sulfonamide en trimethoprim) 
werden gevonden. Er werd echter geen fenotypisch detecteerbare verworven resistentie tegen 
routinematig gebruikte desinfectantia gevonden, terwijl resistentiegenen aanwezig waren. De 
meeste APEC stammen waren slechts gemiddelde biofilmvormers op polystyreen, terwijl zij 
op polypropyleen en polyvinyl chloride sterke biofilmvomers waren. Daarom werd de 
efficaciteit van twee van de vijf geselecteerde actieve bestanddelen van desinfectantia (H2O2 
en QAC) om sessiele cellen te doden getest. H2O2 en QAC waren in staat om alle 
aanhechtende cellen te doden bij een concentratie van respectievelijk 1% en 0,01%. 
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Normaal worden desinfectantia gebruikt om ziekte-overdracht tussen opeenvolgende tomen in 
een stal te voorkomen, waarbij het aantal specifieke pathogenen zoveel mogelijk wordt 
verlaagd. In deze studie werd echter de efficaciteit van verneveling van lage concentraties 
H2O2 bepaald om de infectiedruk in aanwezigheid van kippen te verminderen. Kippen die 
respiratoir blootgesteld werden aan APEC en vervolgens aan 2% H2O2 hadden echter een 
hogere kans een hoge letsel score, veroorzaakt door APEC, te ontwikkelen dan kippen die 
werden blootgesteld aan APEC en vervolgens aan 1% H2O2 of gedestilleerd water. Dus H2O2 
verneveling in aanwezigheid van kippen wordt ontraden. 
Tijdens het tweede deel van de studie werd een bioluminescente APEC stam (CH2-lux) 
ontwikkeld door transpositie van het lux operon van Photorhabdus luminescens in de stam die 
gebruikt wordt voor de infectie-studies (CH2). De transpositie van het lux operon in het 
chromosoom van de APEC stam had geen invloed op de virulentie van de laatstgenoemde 
stam, noch de gevoeligheid aan lytische bacteriofagen (fagen). Ex vivo werden correlaties 
gevonden tussen de luminescentie en de concentratie bacteriën in het gehomogeniseerde hart, 
de lever en de longen van vier weken oude CH2-lux geïnfecteerde kippen. De gemerkte stam 
kan ook gebruikt worden om de kennis van de pathogenese van de ziekte te verbreden, om 
gerichte behandelingen tegen colibacillose te vinden. Een bacteriofaagcocktail, samengesteld 
uit vier fagen, werd na een in vitro selectie van de fagen ontwikkeld. De cocktail werd 
toegediend aan experimenteel geïnfecteerde kippen via de trachea, oesophagus of via het 
drinkwater. Behandelde groepen toonden echter geen significante daling in mortaliteit, letsel 
scores of gewichtsverlies in vergelijking met geïnfecteerde/onbehandelde groepen. De 
resultaten impliceren dat hoewel de faagcocktail de infectiestam (CH2) in vitro efficiënt kon 
lyseren, de faagcocktail experimenteel geïnfecteerde kippen niet succesvol kon genezen. Dus 
meer onderzoek is nodig om het therapeutische en profylactische in vivo effect van fagen te 
analyseren. De ontwikkelde luminescente APEC stam kan daarbij mogelijk oplossingen 
bieden. 
Tijdens dit onderzoek werden verschillende experimenten uitgevoerd om het gebruik van 
desinfectantia en bacteriofagen te evalueren teneinde aviaire colibacillose te verminderen. 
Hoewel het veel waardevolle resultaten heeft opgeleverd, is er nog veel onderzoek nodig om 
de kennis voor het gebruik van desinfectantia en bacteriofagen uit te bereiden in de strijd 
tegen colibacillose. 
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Summary 
 
Avian pathogenic Escherichia coli (APEC) cause yearly a huge economic damage to the 
poultry industry due to mortality, slower growth, a lower feed conversion efficiency and 
condemnation of carcasses at the abattoir. Inhalation of dust contaminated with high 
concentrations of Escherichia coli can infect the air sacs and lungs, whereafter bacteria can 
enter the bloodstream, causing systemic disease (known as colibacillosis). 
The disease is traditionally treated with antibiotics, but due to frequent use of antibiotics 
many APEC strains have become multidrug resistant. The use of antibiotics raises a public 
health concern, due to transfer of resistance genes/resistant bacteria from animals to humans. 
Therefore in this study the use of disinfectants and bacteriophage therapy were tested as 
alternative prophylaxis/treatment for colibacillosis in chickens.  
First, antibiotic resistance of a selection of APEC strains (n = 97), representative for the 
Belgian laying hen industry, was determined since APEC isolates from laying hens are less 
studied than isolates from broilers. Furthermore, it was determined if these APEC isolates 
were resistant against the most included active ingredients (formaldehyde, glutaraldehyde, 
glyoxal, hydrogen peroxide (H2O2), and a quaternary ammonium compound (QAC)) in 
routinely used disinfectants in the poultry industry. The biofilm-forming capacity of the 
strains was determined on materials frequently used in poultry barns, since biofilm formation 
can have an effect on the efficacy of disinfectants. High resistance percentages were found 
against antibiotics frequently used in the poultry industry (ampicillin, nalidixic acid, 
sulfonamides and trimethoprim). However, no phenotypically detectable acquired resistance 
against routinely used disinfectants could be found, while resistance genes were present. Most 
APEC strains were only moderate biofilm producers on polystyrene, while on polypropylene 
and polyvinyl chloride they were strong biofilm producers. Hence, the efficacy of two of the 
five selected active ingredients in disinfectants (H2O2 and QAC) was tested to eliminate 
sessile cells. H2O2 and QAC were able to eliminate all adhering cells at a concentration of 1% 
and 0.01%, respectively. 
Normally, disinfectants are used in poultry houses to prevent disease carry-over between 
sequential flocks, whereby the number of specific pathogens is lowered as much as possible. 
However, during this study the efficacy of nebulization of low concentrations of H2O2 to 
reduce infection pressure in the presence of chickens was determined. Chickens respiratorily 
exposed to APEC and subsequently to 2% H2O2 had nonetheless a higher chance of 
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developing a high lesion score associated with APEC, than chickens that were exposed to 
APEC and subsequently to 1% H2O2 or distilled water, contraindicating H2O2 nebulization in 
the presence of chickens. 
During the second part of the study, a bioluminescent APEC strain (CH2-lux) was developed 
by transposition of the lux operon of Photorhabdus luminescens in the strain used for 
infection studies (CH2). The transposition of the lux operon into the chromosome of the 
APEC isolate did not affect the virulence of the latter strain, nor its sensitivity for lytic 
bacteriophages (phages). Ex vivo correlations were found between the luminescence and 
bacterial numbers in the homogenized heart, liver and lung of four-week-old CH2-lux 
infected chickens. The marked strain can also be used to increase knowledge on the 
pathogenesis of the disease, in order to find targeted treatments against colibacillosis. A 
bacteriophage cocktail composed of four phages was developed after an in vitro selection of 
the phages. They were administered to experimentally infected chickens intratracheally, intra-
esophageally or via the drinking water. However, treated groups did not show a significant 
decrease in mortality, lesion scores or weight loss compared to infected/untreated groups. The 
results indicate that even though in vitro the phage cocktail efficiently lysed the infecting 
strain, the phage cocktail could not cure experimentally infected chickens. More research is 
needed to analyze the in vivo therapeutic and prophylactic effect of phages. The developed 
luminescent APEC strain can thereby possibly provide solutions. 
During this study various experiments were performed to evaluate the application of 
disinfectants and bacteriophages to reduce avian colibacillosis, even though many valuable 
results were found, still much research is needed to expand knowledge on the use of 
disinfectants and bacteriophages in the battle against colibacillosis. 
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List of abbreviations 
 
AAS   abdominal air sacs 
AFEC    avian faecal Escherichia coli 
AMC   amoxicillin/clavulanic acid 
AMP   ampicillin 
APEC   avian pathogenic Escherichia coli 
ATCC 25922   American Type Culture Collection strain 25922 
ATM    aztreonam 
a.u.   arbitrary units 
BHIB   brain heart infusion broth 
CAZ    ceftazidime 
cfu    colony forming units 
CFX    cefoxitin 
CHL    chloramphenicol 
CI   confidence interval 
CLSI    Clinical and Laboratory Standards Institute 
CS    conserved segment 
CSA    Columbia sheep blood agar 
CTRX   ceftriaxone 
CTX    cefotaxime 
dpi    days post infection 
dpv   days post vaccination 
DR   drinking water 
DW   distilled water 
E. coli   Escherichia coli 
ECOR   Escherichia coli Reference Collection 
EFX    enrofloxacin  
EPS   exopolysaccharide  
ES   esophagus 
ESBL    extended spectrum beta-lactamase 
ExPEC   extraintestinal pathogenic Escherichia coli 
FELASA  Federation of European Laboratory Animal Science Associations 
FOR   formaldehyde 
g   gram 
GEN    gentamicin 
GFP   green fluorescent protein 
GLU    gluteraldehyde  
GLY    glyoxal  
h   hour 
H2O2    hydrogen peroxide 
Intl1, intl2, intl3  integrase class gene 1, 2, 3 
IT   intratracheally 
LB   Lysogeny broth 
LPS   lipopolysaccharides 
Luc    firefly luciferase  
LU-L   left lung 
LU-R   right lung 
Lux   bacterial luciferase 
MBC    minimum bactericidal concentration  
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MHA    Mueller-Hinton agar 
MHB    Mueller-Hinton broth 
MIC    minimum inhibitory concentration  
min   minute 
MOI   multiplicity of infection 
NAL    nalidixic acid 
N.D.   not determined 
NEO    neomycin  
NMEC  neonatal meningitis Escherichia coli 
OD   optical density 
ODc   cut-off optical density  
PBS   phosphate buffered saline 
PCR   polymerase chain reaction 
PEG   polyethylene glycol  
pfu    plaque forming units 
phages   bacteriophages 
PP     polypropylene  
PRD   pericardium 
PS     polystyrene  
p/s/cm2/sr  photons per second per square centimeter per steradian  
PVC   polyvinyl chloride 
Q1    first quartile 
Q3   third quartile  
QAC   quaternary ammonium compound  
ROI   region of interest 
rpm   rotations per minute  
RT    room temperature  
s   second 
SD   standard deviation 
SHS   swollen head syndrome 
SOC   super optimal broth with catabolite respression 
SSC   stainless steel coupon 
SULFA   sulfonamides 
TAS-L   left thoracic air sac 
TAS-R  right thoracic air sac 
TET    tetracycline 
TMP    trimethoprim 
TOT   total lesion score 
TSB   tryptone soya broth 
UPEC    uropathogenic Escherichia coli 
WGA   wheat germ agglutinin-Alexa fluor 488       
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1. Avian pathogenic Escherichia coli 
Escherichia coli (E. coli) are Gram-negative, rod-shaped, facultative anaerobic bacteria and 
are part of the family of the Enterobacteriaceace. They are normal residents of the alimentary 
tract of humans and homoeothermic animals (Hartl and Dykhuizen, 1984; Souza et al., 1999; 
Tenaillon et al., 2010) and their presence in the lower intestine is beneficial to the host, since 
they will synthesize vitamin K (Bentley and Meganathan, 1982) and prevent the intestines 
from colonization by pathogenic bacteria (Hudault et al., 2001; Reid et al., 2001; Tenaillon et 
al., 2010). Between 104 - 107 colony forming units (cfu) of E. coli per gram of faeces are 
usually present in the intestinal contents of birds (Dho-Moulin and Fairbrother, 1999). More 
recently, it was confirmed with 16S rRNA gen amplicon sequencing that E. coli makes up an 
important part of the microbial population in the gastrointestinal tract (Sekelja et al., 2012). 
Part of these E. coli strains are however pathogenic. It was shown that the proportion potential 
pathogenic E. coli declines with age, at placement of broiler chicks making up about 24% and 
by week five only 1% of the flora (Kemmett et al., 2013). In addition, (non-)pathogenic E. 
coli can be isolated from the bird’s skin and feathers (Dho-Moulin and Fairbrother, 1999). 
Pathogenic E. coli can cause disease in mammals and birds and can be separated into two 
major subgroups, based on their pathogenic characteristics: pathogenic E. coli causing 
intestinal infections and pathogenic E. coli causing extraintestinal pathogenic 
infections (ExPEC). The intestinal pathogenic E. coli group includes many pathotypes, such 
as diffusely adherent, enteroaggregative, enterohemorrhagic, enteroinvasive, 
enteropathogenic, and enterotoxigenic E. coli (Kaper et al., 2004), even though recently it was 
shown that an enteroaggregative E. coli strain was the cause of a community-acquired 
outbreak of urinary tract infection in Denmark (Boll et al., 2013). These intestinal pathogenic 
E. coli strains are normally not found in the faecal flora of healthy individuals, they cause 
infection when contaminated food or water is ingested (Smith et al., 2007).  
The ExPEC group can be further subdivided into pathogens responsible for urinary tract 
infections (UPEC) and E. coli causing neonatal meningitis (NMEC). Furthermore there is a 
pathotype of ExPEC causing infection in avian species, better known as avian pathogenic E. 
coli (APEC).  
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1.1. Pathogenesis of APEC 
APEC often starts as a local infection of the air sacs, known as airsacculitis. This is believed 
to be caused by inhalation of dust in the barn contaminated with faeces containing up to 106 
cfu of E. coli per gram (Dho-Moulin and Fairbrother, 1999; Dziva and Stevens, 2008). Air 
sacs are vulnerable for bacterial infection due to a lack of resident macrophages and they are 
dependent on the recruitment of heterophils followed by macrophages (Ficken and Barnes, 
1989; Stearns et al., 1987; Toth et al., 1987; Toth and Siegel, 1986). Furthermore, APEC 
causes frequently an opportunistic infection where chickens experience a viral/mycoplasma 
infection. Viral live vaccines may also predispose chickens to infection (La Ragione and 
Woodward, 2002; Nakamura et al., 1994). The main factor, however, is stress, mainly the 
cause of the high infection pressure due to poor housing conditions (such as high ammonia 
concentrations and high levels of faeces contaminated dust) (Barnes et al., 2008; Dziva and 
Stevens, 2008). However, stress causing an elevation in the level of glucocorticoids, due to 
for example overcrowding also plays a predisposing role (Cheville, 1979). After causing 
airsacculitis the disease can spread through the whole body, entering the bloodstream most 
likely via the air sacs (Ackermann and Cheville, 1991; Pourbakhsh et al., 1997a) and lungs 
(Pourbakhsh et al., 1997a), resulting in a generalized infection. APEC, however, can survive 
inside macrophages providing another potential way to enter the bloodstream (Mellata et al., 
2003; Pourbakhsh et al., 1997b). After the bacteria entered the blood (septicemia) they can 
cause infection of the pericardium (pericarditis) and liver (perihepatitis) (see Figure 1.1), 
collectively called colibacillosis. Another plausible route of infection is via active gut 
translocation, but this probably happens only in the presence of a stressor (Leitner and Heller, 
1992). The disease causes infection in avian species of all ages and leads yearly to 
multimillion-dollar losses in the poultry industry, due to mortality, reduced growth and feed 
conversion efficiency and an increased condemnation of carcasses at the slaughterhouse 
(Barnes et al., 2008; Dho-Moulin and Fairbrother, 1999). It mainly causes disease in chickens 
between 4 and 9 weeks with mortalities up to 20% (Dho-Moulin and Fairbrother, 1999).  
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               Figure 1.1. Typical clinical APEC symptoms 
                 A) perihepatitis, B) pericarditis. 
 
APEC can also cause acute or chronic salpingitis in broiler breeders or laying hens (Bisgaard 
and Dam, 1980, 1981). Salpingitis in these chickens is probably the result of an ascending 
infection from the cloaca (Bisgaard and Dam, 1980) and can lead to the loss of egg laying 
capability (Dho-Moulin and Fairbrother, 1999). Furthermore, an infected laying hen can in 
this way infect the internal egg before shell formation, which can lead to mortalities in 
embryos or chicks up to three weeks after hatching (Barnes et al., 2008). However, the main 
route of infection is through contamination of the eggshell after laying. In chicks this can 
cause yolk sac infection and omphalitis (Barnes et al., 2008; Dho-Moulin and Fairbrother, 
1999). 
In broilers, APEC can also cause cellulitis or necrotic dermatitis of primarily the lower 
abdomen and thighs (Dho-Moulin and Fairbrother, 1999), not leading to mortalities but to 
condemnation of carcasses in the abattoir (Mellata et al., 2003). The lesions are induced by 
the secretion of an E. coli heat-labile, vacuolating cytotoxin (Quel et al., 2013). The incidence 
of the disease has lately increased (Quel et al., 2013), probably due to multiple factors of 
which increased use of high-yield broilers, together with a high barn density are the main 
factors (Nunes, 2011). 
Also, APEC can cause swollen head syndrome (SHS) in broilers and broiler breeders. This is 
a secondary infection of APEC after an avian pneumovirus infection, causing acute rhinitis, 
there is subsequently an invasion of facial subcutaneous tissues by APEC (Hafez and Löhren, 
1990; Picault et al., 1987). Infectious bronchitis virus has also been isolated from broilers 
A
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with SHS showing that other viruses may also be associated with SHS (Droual and 
Woolcock, 1994; Morley and Thomson, 1984). Nakamura et al. (1998) was even able to 
reproduce SHS in chickens with APEC alone, showing the primary importance of APEC in 
the disease. The disease affects mostly broilers between 4 to 5 weeks of age and broiler 
breeders between 24 to 36 weeks of age (Hafez and Löhren, 1990). In broiler breeders this is 
accompanied with a drop in egg production reaching 2-3% and a mortality between 3-4% 
(Morley and Thomson, 1984). 
 
1.2. Characterization 
The O (somatic) antigen of lipopolysaccharides (LPS), the major component of the outer 
membrane of E. coli, is the outermost domain of the LPS molecule. LPS is an endotoxin, and 
induces a strong immune response in a normal healthy human or animal. Serotyping of the O 
antigen is commonly used for estimating the pathogenic potential of APEC strains, since 
some serogroups such as O1, O2, O8, O18 and O78, are detected more often than other 
serogroups (Ewers et al., 2007; McPeake et al., 2005; Rodriguez-Siek et al., 2005b; Schouler 
et al., 2012; Vandekerchove et al., 2005). However, more and more serogroups have been 
identified as being associated with APEC, of which many are untyped (Ewers et al., 2007). 
Therefore, it is believed that serotyping is not a very specific diagnostic tool. Moreover, since 
avian faecal E. coli (AFEC) strains have also been shown to belong to a wide range of 
overlapping serogroups (Rodriguez-Siek et al., 2005b; Schouler et al., 2012).  
A huge set of virulence genes associated with bacterial adhesion, serum resistance, invasion, 
iron acquisition and toxin production have been shown to be important for APEC 
pathogenesis. They are often associated with pathogenicity islands and other mobile DNA 
elements (genes like tsh, iss and iutA, coding for temperature-sensitive hemagglutinin, 
increased serum survival and the receptor for ferric aerobactin, respectively). The gene iss is 
expected to have a link with high level resistance to the complement-mediated bactericidal 
effects of serum, however, the exact mechanism by which it does that is unknown. The 
described genes are also often detected in AFEC, but generally in a lower percentage (Ewers 
et al., 2007; Rodriguez-Siek et al., 2005b). Multiplex polymerase chain reactions (PCRs) have 
been developed to screen for virulence genes associated with APEC, AFEC, NMEC and 
UPEC (Ewers et al., 2005; Schouler et al., 2012; van der Westhuizen and Bragg, 2012). 
Furthermore, it was recently shown that virulence associated gene prevalence in broilers 
decreased with age (Kemmett et al., 2013). It is known that the microbiota in the gut of young 
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chicks is very diverse in comparison to older chickens. Chicks get colonized quickly by E. 
coli via different sources, such as the hatchery environment and the parent flock (Fasenko et 
al., 2009; Petersen et al., 2006). The decrease in percentage of potential APEC can be 
explained by the persistence of strong colonizers (resident strains) and the loss of transient 
strains (Kemmett et al., 2013). Possibly, different virulence genes can provide specific 
advantages in different stages of development (Kemmett et al., 2013; Tenaillon et al., 2010) 
Phylogenetic typing divides isolates in four major phylogenetic groups of E. coli (A, B1, B2, 
and D) (Clermont et al., 2000; Herzer et al., 1990). This typing can be performed using a 
multiplex PCR on genes chuA (required for heme transport in enterohemorrhagic O157:H7 E. 
coli), YjaA (the function is unknown) and an unknown DNA fragment (TSPE4.C2), as shown 
in Figure 1.2 (Clermont et al., 2000).  
                       
Figure 1.2. Decision three to determine the phylogenetic group of an E. coli strain (A, B1, B2 or 
D) based on the results of a multiplex PCR on genes chuA, yjaA and an unknown DNA fragment 
(TspE4.C2) (Clermont et al., 2000). 
  
Most APEC isolates fell into ECOR (E. coli Reference Collection) group A and B2 (Ewers et 
al., 2009; Ewers et al., 2007) or A and D (Rodriguez-Siek et al., 2005a) depending on the 
study, while most AFEC isolates belong to group D (Ewers et al., 2009). Certain AFEC 
strains were, however, also capable of causing systemic disease in five-week-old chickens, 
these strains showed a virulence associated gene pattern very similar to ExPEC strains. This 
led to the hypothesis of an avian intestinal reservoir that might be able to directly transfer to 
humans or through exchange of virulence and resistance genes with ExPEC, showing a 
zoonotic risk (Ewers et al., 2009; Ewers et al., 2007). Phylogenetic group B2 is known to 
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contain highly pathogenic human ExPEC strains (Clermont et al., 2000; Ewers et al., 2007; 
Moulin-Schouleur et al., 2007; Rodriguez-Siek et al., 2005a), while most human commensal 
fall into group A (Clermont et al., 2000). 
 
1.3. Prophylaxis and treatment 
First of all it is important to prevent disease introduction (external biosecurity) by a good 
design of the interior and exterior of buildings, design and positioning of equipment and a 
coordinated planning and programming of vehicle movement (Bermudez and Stewart-Brown, 
2008). A good design of the exterior of buildings means first of all that they should be 
constructed in such a way that wild birds cannot enter the poultry house, since they are 
carriers of various diseases and their faeces is a source of pathogenic E. coli (Barnes et al., 
2008; Bermudez and Stewart-Brown, 2008). The faeces of rodents is also a source of APEC, 
therefore, they should be limited as much as possible in and around the barn (Barnes et al., 
2008; Bermudez and Stewart-Brown, 2008). Barns should also be built so that the chickens 
are protected from the elements, but still provide adequate ventilation (Bermudez and 
Stewart-Brown, 2008). Vandekerchove et al. (2004) found that the density of hens in the 
cages and the distance between poultry farms are of importance for colibacillosis outbreaks in 
flocks of laying hens, so these factor should also be taken into consideration. The interior of 
buildings, such as the floors and cages should be made of materials which are easy to clean 
and disinfect, to lower the number of pathogens in-between consecutive flocks (Bermudez 
and Stewart-Brown, 2008). All these and many more factors should be considered during the 
construction of the buildings, however, not only disease prevention is important for farmers, 
also economic and welfare factors should be taken into account. The final decision for a 
specific design is often a trade-off between these different factors and depends on the 
outcome of a cost/benefit analysis. 
One of the most important predisposing factors for APEC infection is a poor housing climate 
(Dziva and Stevens, 2008). High concentrations of dust or ammonia, due to for example 
improper ventilation, lead to increased infection pressure for the chickens (Bermudez and 
Stewart-Brown, 2008). The different environmental parameters, like humidity, temperature, 
ventilation, ammonia concentration and dust level should therefore be properly controlled in 
order to prevent disease. In addition, management practices like frequent removal of dead and 
moribund hens (Bermudez and Stewart-Brown, 2008), adding chlorine to the drinking water 
(Barnes et al., 2008; Dhillon and Jack, 1996; Gross, 1994) and use of pelleted feed are 
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important (Barnes et al., 2008; Gross, 1994). A good tool for (poultry) farmers to assess the 
biosecurity at their own (poultry)farm is based on a scientific questionnaire (Dewulf et al., 
2014).  
To limit the transfer of pathogens from flock to flock, the poultry house should be properly 
cleaned and disinfected between flocks. Therefore it is important to work with an all-in/all-out 
system (Bermudez and Stewart-Brown, 2008). 
Furthermore, disposal of damaged and faecal contaminated eggs is important to prevent 
disease (Barnes et al., 2008; Dho-Moulin and Fairbrother, 1999). Another more direct way of 
controlling APEC is competitive exclusion by administration of normal bacterial flora from 
healthy chickens or monocultures outcompeting the pathogenic bacteria in the intestinal flora 
of day-old chickens. These cultures can for example be given via intra-gastric intubation, by 
gavage into the crop or orally on hatching in order to establish a mature gut flora early in life. 
However, results are quite variable and challenge strains are usually still present, but in 
reduced numbers (Hakkinen and Schneitz, 1996; Hofacre et al., 2002; La Ragione et al., 
2001; Weinack et al., 1981). 
 
1.3.1. Vaccination 
Live vaccines 
A lot of effort has been put in the development of an effective live attenuated vaccine. 
However, success rates varied and all have in common that they are not able to provide 
efficacious cross-immunity against heterologous APEC strains (Amoako et al., 2004; 
Kariyawasam et al., 2004a; Kwaga et al., 1994; Peighambari et al., 2002). Therefore, it was 
hypothesized that a vaccine containing different serogroups could provide a more efficacious 
protection (Kariyawasam et al., 2004a). Even though this sounds like a plausible solution, it 
might not give sufficient protection, since strains possess different virulence genes, even 
within a serogroup.  
Recently, a live commercial available aroA-deleted (responsible for biosynthesis of aromatic 
amino acids) O78 E. coli vaccine (Poulvac® E. coli, Zoetis) was developed and shown to 
cause a reduction in incidence and severity of airsacculitis when vaccinated chickens were 
challenged with a heterologous serogroup (untypable strain) (La Ragione et al., 2013). 
However, since systemic disease is generally caused by more virulent strains (Pourbakhsh et 
al., 1997b), than the strain used in the study by La Ragione et al. (2013), its efficacious 
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protection against more pathogenic strains remains unclear.  
Live recombinant vaccines can be used to express APEC antigens. Roland et al. (1999; 2004) 
and Chaudhari et al. (2013) used a live attenuated Salmonella typhimurium delivery system, 
targeting mucosal cells in the gut, thus stimulating mucosal immunity as well as humoral and 
cellular immunity (Sirard et al., 1999). Roland et al. (1999; 2004) used this system to express 
E. coli O78 LPS or E. coli O78 LPS and type 1 fimbriae and obtained homologous protection, 
but not heterologous protection. Chaudhari et al. (2013) used the Salmonella typhimurium 
delivery system to express multiple APEC virulence genes (papA, papG, iutA and clpG). 
PapG and papA are P fimbriael genes, while iutA codes for a ferri-siderophore receptor and 
clpG is a CS31A fimbrial adhesin. They found significant protection after immunization 
(Chaudhari et al., 2013) and could increase the protection rate from 75% to 90% when 
immunized along with E. coli heat-labile toxin B subunits, as adjuvant (Chaudhari and Lee, 
2013). However, so far only one challenge strain of serogroup O2, that contained at least 
genes iutA and clpG was tested (Matsuda et al., 2010), more strains of different serogroups 
should be tested before firm conclusions can be drawn about its broad effectiveness. 
Nowadays, the poultry industry is more moving towards in ovo immunization, facilitating the 
vaccination process, since vaccination is performed when eggs are transferred from the setter 
to the hatcher. Nagano et al. (2012) found partial protection (mortality dropped from 100 to 
0%) against APEC when performing in ovo immunization with an attenuated E. coli mutant, 
without affecting hatching or chick survival.  
Inactivated vaccines 
Several inactivated APEC vaccines have been developed, which constitute of a (mixture of) 
killed strain(s) (Melamed et al., 1991; Rosenberger et al., 1985). 
However, these vaccines will not provide a sufficient humoral immune response in broiler 
chickens when administered prior to 10 d of age, since the chickens immune system is not 
fully developed prior to this age (Mast and Goddeeris, 1999). Melamed et al. (1991) obtained  
homologous and heterologous protection against strains O78:K80 and O2:K1, when 
immunizing chickens with an ultrasonically inactivated and irradiated O78:K80 and O2:K1 
strain, respectively. Rosenberger et al. (1985) could protect progeny against homologous 
strains till two weeks post hatch via immunization of broiler breeder hens. Passive maternal 
immunity of chickens can provide protection during early chick life and has as main 
advantage that individual chickens do not need to be immunized in the broiler industry 
(Kariyawasam et al., 2004b). The duration of protection might however not be long enough to 
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protect laying hens and breeders and even broilers, since APEC infection usually occurs 
between 2 to 12 weeks of age, with most losses occurring during week 4 to 9 (Dho-Moulin 
and Fairbrother, 1999).  
Subunit vaccines 
Various subunit vaccines have been developed targeting (a) surface-exposed antigen(s) found 
in most APEC, independent of serogroup. In this way vaccines can be obtained providing 
broad protection against colibacillosis. These antigens can for example be complete fimbriae 
(type 1 or P) or their subunit adhesins, since these were shown to be important for E. coli 
adhesion to host cells. Type 1 fimbriae are important in the initial stages of adherence to 
respiratory epithelium (Dozois et al., 1994; Dozois et al., 1995; Gyimah and Panigrahy, 1988; 
La Ragione et al., 2000; Vidotto et al., 1997), while P fimbriae seem more important during a 
later phase in the infection process, as they are expressed only when present in the air sacs, 
lungs, blood and internal organs (Pourbakhsh et al., 1997b; Pourbakhsh et al., 1997c). 
Gyimah et al. (1986) was able to provide a good protection against respiratory tract infection 
when challenging chickens with strains O1, O2 and O78, after immunizing chickens with a 
mixture of fimbriael proteins of E. coli strains O1, O2 and O78. Vandemaele et al. (2006; 
2005) however, were not able to find protection by immunization with respectively type 1 
fimbriae (FimH) and the sugar binding domain of PapGII (an adhesion of P fimbriae). Type 1 
and P fimbriae (or its adhesins) might not be as important as thought for APEC infection 
(Vandemaele et al., 2006; Vandemaele et al., 2005), as pap-negative and a Δfim mutant(s) 
were still virulent (Li et al., 2005; Marc et al., 1998; Stordeur et al., 2004). Recently, it was 
demonstrated that immunization with the lectin domain of FimH (and whole fimbriae) elicits 
an immune response that enhances the binding of FimH to its receptor, enhancing the cell 
adhesion of E. coli to host cells (Tchesnokova et al., 2011). A commercially available vaccine 
consisting of P fimbriael and flagellar antigens (Nobilis® E. coli Inac, MSD Animal Health) 
claims to protect broiler chickens during the first seven weeks of life, by vaccination of 
broiler breeders.  
Inclusion of iron receptor genes or proteins in a subunit vaccine can also be an option to 
prevent APEC, since iron uptake is essential for proliferation of E. coli. The aerobactin iron-
acquisition uptake system, which is a high-affinity system for iron acquisition to overcome 
growth limitation caused by insufficient amounts of free iron in the body fluids (Warner et al., 
1981), was shown to be significantly more present in pathogenic than non-pathogenic strains 
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(Dozois et al., 1992; Linggood et al., 1987). The outer membrane receptor IutA binds the 
aerobactin complex and transports it into the cell. However, Tuntufye et al. (2012b) could not 
find significant protection against APEC when immunizing chickens with an E. coli subunit 
vaccine expressing ferri-siderophore receptor proteins FepA, FhuE, IroN and IutA.  
Lynne et al. (2012) developed a subunit vaccine consisting of iss fusion proteins, as the iss 
gene was shown to be significantly more present in APEC than AFEC (Kemmett et al., 2013; 
Rodriguez-Siek et al., 2005b). Immunized chickens had significantly lower lesion scores than 
non-immunized chickens after challenge with strains O1, O2 and O78. These challenge 
strains were, however, not highly pathogenic (they showed only a low mortality percentage in 
chickens), so other more pathogenic strains should be tested before general conclusions can 
be drawn about protection against colibacillosis.  
Even though very promising results have been found and some APEC vaccines are already 
available, much is still unknown about the virulence of APEC strains which show great 
diversity, limiting the possibilities of vaccination. 
 
1.3.2. Antibiotic treatment and resistance 
Colibacillosis is traditionally controlled by the use of antibiotics, especially beta-lactams, 
tetracyclines, sulfonamides and (fluoro)quinolones (Dho-Moulin and Fairbrother, 1999; 
Gross, 1994), with as a consequence the risk of antibiotics residues ending up in food, 
selecting for resistance to antibiotics in human bacteria (Singer & Hofacre, 2006). Antibiotic 
resistance in APEC not only causes failure of therapy in animals, but may even lead to 
treatment problems in humans infected with E. coli strains from animal origin (Blake et al., 
2003; Smet et al., 2011; van den Bogaard and Stobberingh, 1999). Resistance in E. coli 
isolates from laying hens in comparison to broilers is in general lower (AFEC as well as 
APEC), but is still widespread (Harisberger et al., 2011; van den Bogaard et al., 2001). While 
layers normally only receive antibiotics during rearing, antibiotic resistance might possibly 
persist for a long period of time in the intestinal tract without selective pressure of antibiotics 
(Chaslus-Dancla et al., 1987).  
Faecal isolates of broilers in Belgium showed high resistance to ceftiofur, which was allowed 
as a third-generation veterinary used cephalosporin until 2000 for prevention of E. coli 
septicemia in one-day-old chickens in Belgium (Persoons et al., 2010; Persoons et al., 2011b; 
Smet et al., 2008). The fast increase of AFEC resistance to ceftiofur (from 5% in 2002 to 37% 
in 2010) (Casteleyn et al., 2006; Persoons et al., 2011a; Persoons et al., 2010) shows that 
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certain E. coli strains can possibly form a reservoir for (antibiotic) resistance genes in the 
chickens’ intestine and can in this way transfer these genes to pathogens (Ewers et al., 2009). 
Smet et al. (2011) showed that extended-spectrum beta-lactamase (ESBL) positive E. coli 
from avian origin was able to persist in situ in a system mimicking the human caecum and the 
ascending colon (even without selective pressure of antibiotics) and was thereby able to 
transfer resistance genes to commensals. After treatment with cefotaxime the number of 
ESBL positive E. coli increased and was able to persist at increased concentrations, increasing 
public health issues (Smet et al., 2011). Leverstein-van Hall et al. (2011) and Overdevest et 
al. (2011) detected a high prevalence of ESBL genes in poultry meat, which shows the 
possibility of transfer of ESBL genes via the food chain to humans. Depoorter et al. (2012) 
developed a model, simulating the farm to fork chain, predicting that consumers have a 
chance of about 1.5% to be exposed to 1000 cfu or more of 3rd generation cephalosporin 
resistant E. coli during consumption of chicken meat, mainly due to cross-contamination in 
the kitchen. Persoons et al. (2011b) identified on-farm antimicrobial therapy (co- or cross-
resistance), management practices (like acidiﬁcation of drinking water) and hatchery-related 
factors (probably off-label use of cetiofur) as risk factors for ceftiofur resistance in AFEC 
from broilers. This means that in order to lower antibiotic resistance occurrence, not only 
reduction of antibiotic use is important, but also good farm practices and even good hatchery 
practices are necessary. So, apart from selection for antibiotic resistance, there is the risk of 
transfer of resistance from animals to humans and the high cost of antibiotic treatment. 
Therefore the use of antibiotics has to be limited as much as possible, however, this increases 
the need for alternative methods.  
 
1.3.3 Bacteriophage therapy 
Treatment by utilization of lytic bacteriophages (phages) gained more interest, due to its 
promising results in vivo (Barrow et al., 1998; Huff et al., 2003a, 2004; Lau et al., 2010; 
Oliveira et al., 2010). Phages were discovered independently by Twort and d’Herelle in the 
beginning of the 20th century. The word bacteriophage was proposed by d’Herelle and 
consists of the words ‘bacteria’ and ‘phagein’ to explain that phages devour bacteria 
(d'Herelle, 1926; Sulakvelidze and Morris, 2001). Bacteriophages can have a lytic cycle or a 
lysogenic cycle, and a few viruses are capable of carrying out both (Huff et al., 2005; Patnaik 
et al., 2012). Phages that undergo the lysogenic cycle will, however, not be discussed here, 
since they are not the preferred candidates for phage therapy. Upon infecting a host, they 
incorporate their genetic material into the genome of the host (known as prophage) and 
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remain dormant until host conditions deteriorate (Huff et al., 2005; Sulakvelidze and Morris, 
2001; Patnaik et al., 2012). Strictly lytic phages are bacterial viruses that attach to their 
specific hosts, followed by internal replication of their genomes, whereafter the first viral 
mRNA is translated into proteins. Sometimes, these early proteins cause degradation of the 
host chromosome. The phages disrupt the host synthesizes of nucleic acids and proteins, and 
force the host to produce viral nucleic acids and proteins instead (Patnaik et al., 2012). These 
proteins are assembled to form new phages, followed by lysis of the host (see Figure 1.3).  
 
           
Figure 1.3. Life cycle of a strictly lytic bacteriophage. A phage particle attaches to a host cell and injects 
its genomic material into the cell. The host cell starts producing viral nucleic acids and proteins, followed by 
assembly of viral proteins. In the last stage, the host cell is lysed by the newly synthesized phages and phages are 
released (www.textbookofbacteriology.net). 
 
Already soon after their discovery, phages were used by d’Herelle for treating patients with 
dysentery, plague and to control cholera epidemics (d'Herelle, 1926; Sulakvelidze and Morris, 
2001; Summers, 2001). These studies gave very promising results, and resulted in the 
production and development of different phage preparations for therapeutic use by companies 
worldwide (Sulakvelidze and Morris, 2001). But with the advent of antibiotics around 1930-
1940, phages became neglected in the Western World. Antibiotics were easier to apply and 
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became worldwide available, phages on the other hand did not always show consistent results. 
Research on phages continued in the former Soviet Union and Eastern Europe but knowledge 
did not disseminate, since most of the work was not published in English. However, with the 
emergence of multidrug resistance, interest in phages was reestablished in the Western World 
and the USA (Sulakvelidze and Morris, 2001).  
Phages have many advantages over antibiotics, such as being ubiquitous in nature, even 
residing in the alimentary tract of humans and animals and are therefore generally considered 
as safe for application to humans and animals (Johnson, 2008). Effective phage therapy 
reduces pathogen numbers, so that the immune response of the host can take over and 
eliminate the remaining infectious bacteria (Levin and Bull, 2004). Several studies concerning 
phage therapy to treat APEC in chickens have been published (Barrow et al., 1998; Huff et 
al., 2003a, 2004; Lau et al., 2010; Oliveira et al., 2010). However, many factors are important 
for an effective phage therapy, such as time of administration, site of administration, the 
applied dose and the application method (Huff et al., 2013; Ryan et al., 2011). So even though 
positive results have been published, the use of phages is far from straightforward and much 
is still unknown about their behaviour in vivo. Moreover, there appears to be an immune 
response towards phages in chickens, leading to decreased therapeutic efficacy of phages after 
prior exposure (Huff et al., 2010). This was shown by an in vitro kinetic assay of phage 
activity, which showed that serum pretreated with phages inhibited phage activity in 
comparison with control serum (as measured by the lowered lysis of the host strain). 
Furthermore, serum from pretreated chickens showed a significant increase in IgG titers in 
comparison with control serum. Huff et al. (2010) therefore suggested that the observed 
efficacy is partly due to an acquired immune response to the administered phages.  
The K1-capsule, a virulence factor of APEC, can prevent phagocytosis by heterophils and 
macrophages due to its negative surface charge and hydrophilic nature. Expression of the 
capsule was shown necessary for causing avian septicaemia (Li et al., 2005). Moreover, the 
K1-capsule can also prevent phages from reaching their receptor (Scholl et al., 2005), 
affecting treatment outcomes. Possibly, colanic acid can also physically block phages from 
reaching their receptor, since it forms a thick slime layer on the outer membrane of E. coli  
(Stevenson et al., 1996). This layer is probably formed to protect APEC against host stresses, 
such as heat, acid and osmotic and oxidative stress (Chen et al., 2004; Mao et al., 2001; 
Tuntufye et al., 2012a). Most likely, the capacity of (some) APEC strains to produce a K1-
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capsule and colanic acid forms also an important obstacle for vaccine development. 
 
1.3.4 Disinfectants 
Cleaning and disinfection of poultry houses and equipment is part of good husbandry 
practices in order to keep spread of pathogens between flocks as low as possible, as is 
fumigation of eggs within two hours after lay, to prevent disease in chicks (Barnes et al., 
2008; Dho-Moulin and Fairbrother, 1999). However, little is known about possible resistance 
of APEC to disinfectants. There are different forms of bacterial resistance to disinfectants, 
namely: intrinsic resistance, genetically acquired resistance or tolerance (Bridier et al., 2011). 
Intrinsic resistance is the innate resistance of an organism for in this case, a specific 
disinfectant. Genetically acquired resistance can be obtained due to horizontal transfer of 
genes via different genetic elements, like transposons, plasmids and integrons, or due to 
chromosomal mutations. Bacteria can become less susceptible or tolerant to a disinfectant due 
to adaptation, growth in a biofilm, being in stationary growth phase or as persister cells. 
(Bridier et al., 2011; Langsrud et al., 2003; Russell, 2003). Persister cells (dormant cells) are 
phenotypic variants of regular cells that arise spontaneously in microbial populations and are 
highly tolerant to antibiotics. However, they are not genetic mutants (Bridier et al., 2011; 
Lewis, 2010). Multidrug efflux pumps (mainly chromosomally encoded), when over-
expressed, can provide simultaneously resistance to antibiotics and disinfectants (cross-
resistance), due to (a) mutation(s) in the promoter region or in insertion elements upstream of 
the transporter gene, in the local repressor gene or in a global regulatory gene (Piddock, 
2006a; Piddock, 2006b). Exposure of clinical Staphylococcus aureus isolates to low 
concentrations of certain biocides or stepwise increasing concentrations of the biocides, 
resulted in mutants overexpressing multidrug efflux pumps (Huet et al., 2008). The most 
studied multidrug efflux pump in E. coli is the AcrAB-TolC pump (Fralick, 1996) (see Figure 
1.4). This pump consists of a cytosplasmic bound transporter of the resistance-nodulation-
division family, AcrB (Tseng et al., 1999), an accessory protein (membrane fusion protein, 
AcrA (Dinh et al., 1994)), and a minor outer membrane protein, TolC (Morona et al., 1983). 
The pump actively transports compounds directly from the cell into the medium (Murakami, 
2002). 
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Figure 1.4. Schematic representation of the AcrAB-TolC efflux pump of E. coli. AcrB is a 
cytosplasmic bound transporter protein that is an energy-dependent (proton motive force) efflux pump, AcrA is a 
membrane fusion protein and TolC is an outer membrane protein (Taylor et al., 2012). 
 
Antibiotic resistance genes and biocide resistance genes on the same genetic mobile element 
can be transferred to other bacteria by horizontal gene transfer (co-resistance) (Coelho et al., 
2013). In the case of E. coli the best known resistance mechanism for quaternary ammonium 
compounds (QAC) is via the qacEΔ1 gene, mostly associated with class 1 integrons. The 
qacE gene codes for an energy-dependent small multidrug resistance efflux pump, whereby 
the pump dependents on proton motive force (Paulsen et al., 1993). QacEΔ1 most likely 
represents a disrupted form of qacE, that was shown to be only partially functional as a 
multidrug exporter (Paulsen et al., 1993). The qacEΔ1 gene is normally found in the 3’-
conserved segment (3’-CS) of class 1 integrons together with the sul1 gene, which encodes 
resistance to sulfonamides (Paulsen et al., 1993). However, different gene arrangements have 
been found in E. coli at the 3’-CS, whereby the qacEΔ1-sul1 fragment was for example 
replaced by qacH-tnp-sul3 (Bischoff et al., 2005; Soufi et al., 2009). Class 1 integrons also 
contain a variable region that can contain one or more mobile gene cassettes, frequently 
coding for antibiotic resistance (Fluit and Schmitz, 2004) (see Figure 1.5). The integrase of 
the integron integrates the antibiotic gene cassettes into the integron. 
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Figure 1.5. Schematic representation of integron class 1. At the 5’CS, the intl1 gene is shown that codes 
for integrase, integrating the resistance gene cassettes into the variable region of the integron. At the 3’CS, genes 
qacEΔ (codes for resistance to QAC) and sul1 (codes for resistance to sulfonamide). AttC: attachment site of the 
cassette; attI: attachment site of the integron; Pant: promoter for expression of the gene cassette; qacEΔ: 
quaternary ammonium compound resistance; R gene: resistance gene; sul1: sulfonamide resistance (Davies, 
2007). 
 
Kücken et al. (2000) and Jaglic et al. (2012) did not find Gram-negative bacteria to be more 
resistant to QAC when possessing either the qacE or qacEΔ1 gene. However, in the Gram-
positive Staphylococcus aureus, a significant higher tolerance to disinfectants QAC and 
chlorhexidine was found when strains carried qac genes (qacA/B or qacC) (Smith et al., 
2008). Increased tolerance in qac positive strains was found, when exposed to increasing 
concentrations of QAC (Smith et al., 2008). However, increased tolerance due to exposure to 
increasing concentrations of benzalkonium chloride (a QAC), was also found in 
Staphylococcus aureus strains not carrying qac genes (Heir et al., 1999), thereby putting in 
question the role of the qac genes in tolerance to cationic disinfectants (Jaglic and 
Cervinkova, 2012). For E. coli, much is still unknown about the role of the qac genes in 
relation to disinfectant resistance, increased tolerance due to exposure to increasing 
concentrations of cationic disinfectants and antibiotic resistance. 
 
1.3.5 Biofilms 
Biofilm formation in bacteria was first observed by Antoni van Leeuwenhoek, when he 
discovered “animalculi” in dental plaque with his early microscope. These “animalculi” were 
responsible for the formation of a biofilm network, but it took till the end of the 20th century, 
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before scientists got really interested in bacterial biofilms (Costerton et al., 1999). Biofilms 
are described as “a sessile community of irreversibly attached cells that are surrounded by an 
extracellular matrix, with an altered growth rate and gene transcription in comparison to 
planktonic cells” (Donlan and Costerton, 2002). The matrix is generally composed of 
exopolysaccharide (EPS), proteins and nucleic acids (Branda et al., 2005; Davey and O'Toole, 
2000). Sessile cells have many advantages for survival over their planktonic counterparts, like 
protection from environmental stressors, better nutrient availability, metabolic cooperation 
and the exchange of genetic material (Davey and O'Toole, 2000). Biofilms are also an 
important obstacle during cleaning and disinfection. They are hard to remove and cells in 
biofilms are in general more resistant (tolerant) to biocides than planktonic cells. There are 
several reasons for this tolerance, (I) reduced biocide penetration in deeper layers of the 
matrix due to the presence of the extracellular matrix, (II) efficacy of disinfectants are 
impaired due to chemical interactions between biocides and biofilm components, such as EPS 
(Russell, 2003). (III) Sessile cells have a different growth rate and cell physiology, leading to 
modifications in the membrane composition and expression of defense mechanisms (Bridier 
et al., 2011; Lisle et al., 1998; Saby et al., 1999). (IV) The presence of degradative enzymes 
within biofilms might inactivate biocides (Bridier et al., 2011; Donlan and Costerton, 2002; 
Russell, 2003). (V) Starvation and oxidative stress in a biofilm, which were shown to increase 
the resistance of  E. coli  to chlorine in less than 24 h (Saby et al., 1999). Starvation was 
identified as one of the major factors influencing the sensitivity of bacteria to 
disinfectants (Berg et al., 1982; Lisle et al., 1998; Matin, 1991; Saby et al., 1999), most likely 
by activation of the reduced glutathione metabolism, which is a major component of cells 
involved in protection against reactive oxygen species (Saby et al., 1999). And (VI) plasmid-
mediated horizontal gene transfer and conjugation between cells in a biofilm (Russell, 2003). 
Different bacterial surface structures have been shown to be important for initial attachment 
of E. coli to surfaces and for actual biofilm formation under various environmental 
conditions. Motility of E. coli strain 2K1056 was shown to be important for the initial 
interaction with a polyvinyl chloride (PVC) surface as well as for movement along the surface 
under nutrient replete conditions (Pratt and Kolter, 1998). Prigent-Combaret et al. (2000) on 
the other hand, showed that in the case of E. coli K-12 strains (overproducing curli) flagella 
are not necessary for initial interaction with polystyrene (PS), when strains are grown in 
nutrient deplete medium. Concluding that depending on environmental conditions, E. coli 
makes use of different pathways for initial attachment to a surface (Prigent-Combaret et al., 
2000). Curli, which are normally expressed under stress conditions (Olsén et al., 1993; Olsén 
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et al., 1989), were important for adhesion of E. coli K-12 strains to PS in nutrient deplete 
medium (Prigent-Combaret et al., 2000; Vidal et al., 1998) as well as for cell-to-cell 
interaction, in order to form a multilayered biofilm (Prigent-Combaret et al., 2000). While 
Ryu et al. (2004b) reported that curli were not important for initial adhesion to stainless steel 
coupons (SSCs), but for the formation of an actual biofilm. Type 1 fimbriae were, however, 
reported to be needed for initial attachment to PS (Pratt and Kolter, 1998). EPS production by 
E. coli O157:H7 on the other hand inhibited attachment to SSCs (Ryu et al., 2004a).  
Biofilm formation of APEC is known to be dependent on many factors, medium being one of 
them. Nutrient deficient conditions in general induce biofilm formation (Skyberg et al., 2007). 
A lot of research has been done on biofilm formation of E. coli in the food industry (Dourou 
et al., 2011; Hood and Zottola, 1997; Patel et al., 2011; Ryu and Beuchat, 2005; Ryu et al., 
2004a; Wang et al., 2012), whereby the choice of materials plays an important role in the 
capacity to form biofilms. The capacity to form biofilms on materials often used in the poultry 
farms is although not frequently studied, even though this has a huge influence on the 
cleaning and disinfectant practices. 
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Objectives of the study 
Traditionally, antibiotics are used to treat chickens infected with colibacillosis. However, due 
to development of antibiotic resistance, other ways of treating chickens have to be found. 
Furthermore, treating laying hens with antibiotics is not practiced, due to residues that may 
end up in the eggs. Vaccination shows varying results, mainly because of the great diversity 
of APEC strains. Therefore alternative methods have to be explored to prevent or treat APEC 
infection. During this study a two-way strategy was tested. On the one hand trying to prevent 
environmental colonization (or flock to flock transmission) of APEC and lowering infection 
pressure in the presence of chickens by the use of disinfectants and on the other hand focusing 
on treating APEC infected chickens by the use of a phage cocktail. The general aim of this 
study was to assess the usefulness of disinfectants and phage therapy in the prevention and 
treatment of APEC infections in poultry. 
 
Disinfectants  
The first specific aim of this study was to determine the sensitivity of a specific collection of 
APEC strains, representative for the Belgian laying hen industry, towards antibiotics and 
active ingredients often included in disinfectants in the poultry industry, and to determine the 
integron prevalence in these strains (Chapter II). 
The second specific aim was to determine the biofilm formation capacity of these APEC 
strains on different materials often used in chicken barns, since biofilms can impair 
disinfectant efficacy, and to determine the efficacy of some disinfectants to destroy biofilms 
(Chapter III). 
The third aim of the study was to determine the efficacy of disinfection by nebulization of 
hydrogen peroxide in order to lower infection pressure in the presence of chickens (Chapter 
IV). 
 
Bacteriophage therapy 
The fourth aim of this study was the development of a bioluminescent APEC strain to monitor 
APEC infection in chickens ex vivo, to be able to determine the effect of phage treatment on 
the course of an APEC infection (Chapter V). 
And the fifth specific aim was to determine the efficacy of a phage cocktail for treating 
chickens that have been experimentally infected with APEC (Chapter VI). 
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Susceptibility of avian pathogenic Escherichia coli from 
laying hens in Belgium to antibiotics and disinfectants and 
integron prevalence 
 
 
 
 
 
 
 
 
       
	
 
 
Adapted from:  
Oosterik, L.H., Peeters, L., Mutuku, I., Goddeeris, B.M., Butaye, P. 2014. Susceptibility of 
Avian Pathogenic Escherichia coli from laying hens in Belgium to antibiotics and 
disinfectants and integron prevalence. Avian Diseases 58 (2), 271-278
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Abstract 
In this chapter, the resistance of APEC isolates (n = 97) from Belgian laying hens to different 
classes of antibiotics was determine, as well as the minimum inhibitory concentrations (MIC; 
agar and broth dilution) and minimum bactericidal concentrations (MBC) of the five most 
included active ingredient in routinely used disinfectants in the poultry industry 
(formaldehyde, glutaraldehyde, glyoxal, hydrogen peroxide, and a quaternary ammonium 
compound). The presence of integrons was determined by PCR.  
Resistance to ampicillin (35.1%), nalidixic acid (38.1%), sulfonamides (41.2%), and 
tetracycline (53.6%) was high, but resistance to other tested antibiotics was low. Nevertheless, 
two ESBL producers were found. The MIC of the disinfectants for the APEC strains showed 
an unimodal distribution, indicating that there was no acquired resistance. MBCs were similar 
to MICs via the broth dilution method, showing the bactericidal effect of the disinfectants. 
Twenty-one strains (21.6%) were found positive for class 1 integrons and a positive 
association between integron presence and resistance to trimethoprim, sulfonamides, and 
tetracycline was found. No association could be found between integron presence and 
phylogenetic group affiliation. 
 
1. Introduction 
Antibiotic resistance among poultry E. coli isolates is common (Harisberger et al., 2011; Smet 
et al., 2008; van den Bogaard et al., 2001; Vandemaele et al., 2002), even though restrictions 
were put on the use of antibiotics by the European Union (Casewell et al., 2003; European 
Parliament, 1998). Laying hens are rarely given antibiotics, since no mass outbreaks of 
colibacillosis occur, only a limited number of laying hens gets infected that are difficult to 
treat, furthermore there is the risk of antibiotic residues ending up in the eggs. The observed 
resistance among faecal E. coli has been reported to be lower in strains from laying hens than 
in strains from broilers, although resistance is widespread (Harisberger et al., 2011; van den 
Bogaard et al., 2001). During rearing however, layers do receive antibiotics, and antibiotic 
resistance can persist for a long time in the intestinal tract of chickens without selective 
pressure of antibiotics (Chaslus-Dancla et al., 1987). Other risk factors for bacterial resistance 
are crowding and poor sanitation. Sanitation, which includes regularly cleaning and 
disinfection, is a good way to lower the bioburden and thereby the level of specific pathogens 
in poultry farms (Moustafa Gehan et al., 2009). However, little is known about resistance to 
disinfectants and the degree of resistance. Only resistance to QACs is relatively well known, 
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which in the case of E. coli is mainly encoded by the qacEΔ1 gene, mostly associated with 
class 1 integrons. This gene, together with sul1, which encodes resistance to sulfonamide, is 
found in the 3’-CS of class 1 integrons (Paulsen et al., 1993). Next to the 3’CS and 5’CS 
region (containing the integrase gene, an integration site and a promoter), class 1 integrons 
have a variable region that can contain one or more mobile gene cassettes, normally coding 
for antibiotic resistance (Fluit and Schmitz, 2004). Furthermore, multidrug efflux pumps, 
mainly encoded on the chromosome, can lower the sensitivity towards disinfectants and 
antibiotics by pumping out the antimicrobials (Poole, 2005) 
In this chapter, we determined the susceptibility of APEC strains, obtained from laying hens 
suffering from colibacillosis, to antibiotics and to frequently used disinfectants in the poultry 
industry. Also, the presence of integrons was investigated and phylogenetic typing of the 
strains was performed. 
 
2. Material and Methods 
2.1. Bacterial strains  
APEC strains (n = 97) were collected from organs (caecum, down, liver, oviduct, 
pericardium/heart, peritoneum, trachea) and faeces/bedding of caged laying hens suffering 
from colibacillosis and kept in Lysogeny broth (LB) supplemented with 50% glycerol at         
-80°C. The strains were from 50 different farms throughout Belgium, collected from the year 
2000 - 2005, and were kindly provided by Dr. Vandekerchove (CODA-CERVA, Brussels, 
Belgium). American Type Culture Collection strain 25922 (ATCC 25922) was used as 
reference strain. Control strains containing the integrase class 1, 2 and 3 gene respectively 
(intl1, intl2, and intl3) from the collection of the university of La Rioja (Logroño, Spain), 
were kindly provided by Prof. C. Torres. Strains FV18088 (chuA and TSPE4.C2) and 
FV18091 (yjaA) were used as control strains for phylogenetic typing and were kindly 
provided by Prof. J. Blanco (University of Santiago de Compostela, Spain). Bacteria were 
routinely grown at 37°C unless stated otherwise.  
2.2. Disinfectants 
The five active ingredients most included in disinfectants, routinely used in poultry farms, 
were selected. These ingredients were: alkyldimethylbenzylammoniumchloride (a QAC, 
50%), formaldehyde (FOR, 35% wt/vol in H2O), glutaraldehyde (GLU, 50% wt/vol in H2O), 
glyoxal (GLY, 40% wt/vol in H2O) and hydrogen peroxide (H2O2, 42.1 % wt/vol in H2O; 
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EcoClearProx®). FOR, GLU, GLY and QAC were obtained from Sigma-Aldrich (Diegem, 
Belgium), H2O2 from ABT Belgium BVBA (Affligem, Belgium).  
2.3. Serotyping 
The following E. coli antisera: O1, O2, O5, O6, O8, O9, O11, O12, O14, O15, O17, O18, 
O20, O35, O36, O45, O53, O78, O81, O83, O88, O102, O103, O115, O116, O132 
(University of Santiago de Compostela, Spain) were used to serotype the E. coli strains using 
the microtitre agglutination test, as previously described (Guinée et al., 1972).  
2.4. Antibiotic susceptibility testing 
Antibiotic susceptibility of the strains was tested with the disk diffusion susceptibility test, 
according to standardized methods from the Clinical and Laboratory Standards Institute 
(CLSI) (CLSI, 2008). Briefly, cultures in brain heart infusion broth (BHIB; Bio-Rad 
Laboratories N.V., Nazareth Eke, Belgium) were made from the stock cultures (-80°C) and 
put overnight in an incubator shaker (Innova 4200, New Brunswick Scientific Europe B.V., 
Nijmegen, the Netherlands) at 230 rotations per minute (rpm). Columbia sheep blood agar 
(CSA) plates (Bio-Rad Laboratories N.V.) were streaked with the overnight cultures and 
incubated for 18 - 24 h. Uniform colonies were picked from the CSA plate and diluted in 
saline (Bio-Rad Laboratories N.V.) till a density of 0.5 McFarland was obtained. The 
suspension was spread on a Mueller-Hinton agar (MHA; CM0337, Oxoid N.V., 
Erembodegem - Aalst, Belgium) plate by streaking with a sterile cotton swap and the surface 
was left to dry, after which the antibiotic discs (Rosco, Taastrup, Denmark) were put on the 
surface with a dispenser. These antibiotics are: ceftriaxone (CTRX; 30 µg), ceftazidime 
(CAZ; 30 µg), cefotaxime (CTX; 30 µg), cefoxitin (CFX; 60 µg), aztreonam (ATM; 30 µg), 
amoxicillin/clavulanic acid (AMC; 30+15 µg), ampicillin (AMP; 33 µg), nalidixic acid 
(NAL; 130 µg), enrofloxacin (EFX; 10 µg), gentamicin (GEN; 40 µg), neomycin (NEO; 120 
µg), chloramphenicol (CHL; 60 µg), tetracycline (TET; 80 µg), trimethoprim (TMP; 5.2 µg) 
and sulfonamides (SULFA; 240 µg). After 18 h incubation, inhibition zones were measured to 
determine whether the different strains were susceptible, intermediate or resistant to the tested 
antibiotics, according to the manufacturer’s guidelines (Rosco, 2004-2005). Strains that 
showed intermediate resistance, were considered as non-resistant. E. coli ATCC 25922 was 
used as reference strain.  
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2.5. Disinfectant susceptibility testing 
 2.5.1. Minimum inhibitory concentration determination 
MICs of the selected disinfectants for the APEC strains were determined with the agar 
dilution and the broth microdilution assay, according to the CLSI (CLSI, 2008). 
2.5.1.1. Agar dilution method 
Fresh APEC cultures were diluted in saline to obtain a culture of approximately 1.5 × 107 
cfu/ml. The susceptibility test was performed on MHA to which two-fold dilutions of the 
disinfectants were added. On every plate the ATCC strain 25922 was inoculated as a control. 
Inoculation was performed with a multipoint inoculation machine (Denley Instruments, 
Billingshurst, UK), whereby approximately 2 × 104 cfu/spot of every strain was inoculated on 
the agar. The plates were inspected for visible growth after incubation for 24 h; the MIC is the 
lowest concentration of disinfectant where no growth could any longer be observed. 
2.5.1.2. Broth microdilution assay 
Two-fold dilutions of the disinfectants were added to test tubes with cation adjusted Mueller-
Hinton Broth, (MHB; CM0405; Oxoid N.V.) after which 50 µl of the disinfectant dilution 
was transferred to the wells of a sterile plastic 96-well microdilution plate (Pittsburgh Corning 
Europe, S.A., Lasne, Belgium). Fresh 24 h incubated (230 rpm) APEC cultures in BHIB were 
diluted in saline, to obtain a concentration of 1.5 × 106 cfu/ml. Fifty µl of these APEC 
cultures was added to the wells of the microdilution plate, yielding a total suspension volume 
of 100 µl (disinfectant and APEC culture). After which the plates were incubated for 24 h, 
whereafter the MICs were read. ATCC strain 25922 was used as control.  
2.5.2. Minimum bactericidal concentration determination 
The MBC of the disinfectants for the different APEC strains was determined by plating the 
suspensions (100 µl) from the microdilution plate where no visible growth was seen, from the 
broth dilution assay, on MHA. The plates were incubated for 24 h, after which MBCs were 
determined. The MBC is the concentration of disinfectant where a 99.9% reduction in 
bacterial numbers could be seen. 
2.5.3. Integron detection 
DNA was extracted using a boiling method. Briefly, strains were overnight incubated (at 230 
rpm) in BHI, after which cultures were spun down at 1,500 × g for 10 min in an Eppendorf 
centrifuge. The pellet was resuspended in 500 µl sterile Milli-Q water and heated in a heating 
28 - Chapter II: Susceptibility of APEC to antibiotics and disinfectants 
 
block at 96ºC for 6 min. Cultures were spun at 6,100 × g for 6 min in an Eppendorf centrifuge 
and the supernatant was transferred to a new Eppendorf tube.  
A multiplex PCR was performed to detect intl1, intl2 and intl3 genes that encode class 1, 2 
and 3 integrases, respectively, using primers previously described (see Table 2.1) (Su et al., 
2006). The QIAGEN Multiplex PCR Kit (QIAGEN, Venlo, the Netherlands) was used, 
according to the recommendations of the manufacturer. The PCR conditions used, were as 
described by Marchant et al. (2013); 94°C (5 min), [94°C (30 s), 54°C (30 s), 72°C (2 min)] 
30 cycles and final extension on 72°C (10 min) was added. Strains containing intl1, 
intl2 and intl3 genes were used as positive controls. The products were visualized on a 2%
agarose gel by transillumination. 
 
Table 2.1. Oligonucleotides used in this chapter 
Primer Sequence (5' to 3') Size 
(bp) 
Target GenBank 
number 
References 
intM1-U ACGAGCGCAAGGTTTCGGT 
565 Intl1 AF550415 
(Su et al., 
2006) intM1-D GAAAGGTCTGGTCATACATG 
intM2-U GTGCAACGCATTTTGCAGG 
403 Intl2 AP002527 
(Su et al., 
2006) intM2-D CAACGGAGTCATGCAGATG 
intM3-U CATTTGTGTTGTGGACGGC 
717 Intl3 AY219651 
(Su et al., 
2006) intM3-D GACAGATACGTGTTTGGCAA 
ChuA.1  GACGAACCAACGGTCAGGAT 
279 chuA 
 (Clermont    
et al., 2000) ChuA.2 TGCCGCCAGTACCAAAGACA 
YjaA.1 TGAAGTGTCAGGAGACGCTG 
211 yjaA 
 (Clermont    
et al., 2000) YjaA.2 ATGGAGAATGCGTTCCTCAAC 
TspE4C2.1 GAGTAATGTCGGGGCATTCA 
152 TSPE4.C2 
 (Clermont    
et al., 2000) TspE4C2.2 CGCGCCAACAAAGTATTACG 
  
2.6. Phylogenetic typing 
The APEC strains (n = 97) were phylogenetic classified according to the ECOR system, using 
a method described earlier (Clermont et al., 2000), with slight modifications. The primers that 
were used are given in Table 2.1. The QIAGEN Multiplex PCR Kit (QIAGEN) was used, 
according to the recommendations of the manufacturer. The PCR conditions were 95ºC for 4 
min (initial denaturation), then 30 cycles consisting of [94ºC for 30 s (denaturation), 59ºC for  
30 s (annealing) and 72ºC for 1 min (elongation)], followed by 72ºC for 5 min (final 
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elongation). The products were visualized on a 1.5% agarose gel by transillumination.  
2.7. Statistics 
 Confidence intervals (CI) were calculated for the resistance percentages of APEC strains to 
the different antibiotics, based on the binominal distribution in Microsoft Excel (2010). The 
same method was performed for determining the number of strains being resistant to different 
classes of antibiotics and for the percentage of strains belonging to serogroup O1, O2 or O78 
containing intl1. Differences between strains containing or not containing an integron and 
being resistant to different classes of antimicrobials were analyzed using the chi-square test, 
since results were given in percentages. The chi-square test was also used to analyze 
differences between strains within serogroup (O1, O2 or O78), belonging to phylogenetic 
group A, B1 or D. P < 0.05 was considered significant. 
 
3. Results 
3.1. Serotyping and selection 
 The APEC strains belonged to serogroup O1 (n = 7), O2 (n = 32) and O78 (n = 58).  
3.2. Antibiotic susceptibility 
The APEC strains were tested for their susceptibility towards different antibiotics (Table 2.2). 
The highest percentages of resistance were detected for AMP (35.1%), NAL (38.1%), SULFA 
(41.2%) and TET (53.6%). Resistance to aminoglycosides (GEN, NEO) was between 0 - 
5.2% and to second and third generation cephalosporins or monobactams (CTRX, CAZ, CTX, 
CFX, ATM) between 0 - 7.2%. Significant differences in resistance against the tested 
antibiotics between serogroups could not be found (P > 0.05). Multidrug resistance, which 
was defined as resistant to three or more classes of antibiotics, was found for thirty-six strains 
(37.1%; see Table 2.3). Two strains were positive for ESBLs. 
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Table 2.2. Number and percentage of resistant APEC strains against antibiotics  
Class Antibiotic N tested N resistant  % resistant (95% CI) 
Cephalosporins Ceftriaxone 97 0 0.0 (0.0 - 4.0) 
 Ceftazidime 97 0 0.0 (0.0 - 4.0) 
 Cefotaxime 97 1 1.0 (0.0 - 6.0) 
 Cefoxitin 97 7   7.2 (3.0 - 14.0) 
Monobactams Aztreonam 97 0 0.0 (0.0 - 4.0) 
Penicillin / penicillin 
combinations 
Amoxicillin/ 
clavulanic acid 
97 0 0.0 (0.0 - 4.0) 
 Ampicillin 97 34      35.1 (25.6 - 45.0) 
Quinolones Nalidixic acid 97 37   38.1 (28.5 - 49.0) 
 Enrofloxacin 97 1        1.0 (0.0 - 6.0) 
Aminoglycosides Gentamicin 97 0        0.0 (0.0 - 4.0) 
 Neomycin 97 5   5.2 (1.7 - 12.0) 
Tetracyclines Tetracycline 97 52   53.6 (43.2 - 64.0) 
Sulfonamides Sulfonamides 97 40   41.2 (31.3 - 52.0) 
Chloramphenicol Chloramphenicol 97 8   8.2 (3.6 - 16.0) 
Trimethoprim Trimethoprim 97 16      16.5 (9.7 - 25.0) 
 
                           Table 2.3. Number and percentage of APEC strains resistant 
                           against total number of different antibiotic classes 
N of antibiotic 
classes resistant 
N of strains % strains (95% CI) 
0 23   23.7 (15.7 - 33.0) 
1 13 13.4 (7.3 - 22.0)  
2 25   25.8 (17.4 - 36.0)  
3 14 14.4 (8.1 - 23.0)  
4 14 14.4 (8.1 - 23.0)  
5 7   7.2 (3.0 - 14.0)  
6 0 0.0 (0.0 - 4.0) 
7 1       1.0 (0.0 - 6.0) 
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3.3. Susceptibility to disinfectants 
The MICs, as determined by the agar dilution and broth microdilution assay, and the MBCs of 
the disinfectants for the 97 tested APEC strains are given in Figure 2.1. For QAC, MICs of 8 - 
32 µg/ml and 64 - 128 µg/ml were found via the broth and agar dilution method, respectively. 
The MBC was between 8 - 32 µg/ml. The MICs of FOR for the APEC strains via the broth 
microdilution assay range between 40 - 80 µg/ml and the MICs via the agar dilution assay 
range between 80 - 160 µg/ml. The MBCs are between 40 - 80 µg/ml. For GLU a MIC of 
1920 µg/ml was found via the broth microdilution method and 1920 - 3840 µg/ml via the agar 
dilution method; the MBC was 1920 µg/ml. The MIC of GLY via the broth and agar dilution 
was between 460 - 1840 µg/ml and 460 - 920 µg/ml, respectively. The MBC was 920 - 1840 
µg/ml. The MIC of H2O2 was 64 µg/ml and 64 - 128 µg/ml for the broth microdilution and 
agar dilution method, respectively. The MBC was 64 µg/ml. All MICs of the disinfectants for 
the strains via the broth dilution method were the same as the MBCs, showing the bactericidal 
effect of the disinfectants. 
3.3.1. Integron detection 
Twenty-one out of 97 strains (21.6%) were found positive for intl1 and none of the strains 
were positive for intl2 and intl3 (see Table 2.4 and Figure 2.2). Three out of seven strains of 
serogroup O1 were found positive for intl1 (42.9%); 4 out of 32 of serogroup O2 (12.5%) and 
14 out of 58 of serogroup O78 (24.1%). No significant differences could be found between 
the serogroups for the presence of intl1 (P > 0.05), possibly due to the low number of positive 
strains.  
3.3.2. Association between antimicrobial resistance and integron presence 
A possible association between antimicrobial resistance and integron presence was analyzed 
by the chi-square test (see Table 2.5). 
Strains containing integron 1 were more resistant to TMP (P < 0.01), SULFA and TET (P < 
0.05) than strains not containing integron 1. A positive association between integron presence 
and resistance to these antibiotics was found. 
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Figure 2.1. Minimum inhibitory (broth dilution and agar dilution method) and minimum bactericidal 
concentrations of 97 APEC strains determined for various disinfectants.   
A) alkyldimethylbenzylammoniumchloride (a QAC); B) formaldehyde (FOR); C) glutaraldehyde (GLU);         
D) glyoxal (GLY); E) hydrogen peroxide (H2O2).  
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                          Table 2.4. Number and percentage of APEC strains containing the 
                           intl1 gene divided over different serogroups 
Serogroup N N total strains % intl1 (95% CI) 
O1 3 7 42.9 (9.9 - 82.0) 
O2 4 32 12.5 (3.5 - 29.0) 
O78 14 58   24.1 (13.9 - 37.0) 
Total 21 97   21.6 (13.9 - 31.0) 
 
 
 
     Figure 2.2. Multiplex PCR on APEC strains for detection of integrase classes 1, 2 and 3. 
      Lane 1 - 14: APEC strains tested for presence of integrase classes 1, 2 and 3. Lane 15 - 18: positive control   
      for integrase class 1, integrase class 2, integrase class 3 and 1, respectively. Lane18: negative control 
      (Milli-Q water). MW is molecular size marker (SmartLadder, Eurogentec, Seraing, Belgium). 
 
3.4. Phylogenetic typing 
Results are summarized in table 2.6. Sixty-nine strains (71.1%) were classified to 
phylogenetic group A, 1 strain belonged (1.0%) to group B1 and 27 strains (27.8%) to group 
D, while none of the strains belonged to group B2. Strains from serogroup O1 and O78 
belonged significantly more to phylogenetic group A compared to the other phylogenetic 
groups. Strains from serogroup O2 belonged more to phylogenetic group D compared to the 
other phylogenetic groups (not significant). 
No significant differences could be found between strains containing or not containing intl1 
and phylogenetic group affiliation (P > 0.05). 
 
           
  
  
 
 
 
Table 2.5. Number of isolates containing or not containing class 1 integrons in relation to their resistance towards different antibiotics 
 Antibiotics and number of resistant isolates (%)B 
Integron 
presenceA 
CTRX CAZ CTX CFX ATM AMC AMP NAL EFX GEN NEO CHL TET TMP SULFA 
+ 
0  
(0.0%) 
0      
(0.0%) 
0   
(0.0%) 
2     
(9.5%) 
0     
(0.0%) 
0   
(0.0%) 
9      
(42.9%) 
10      
(47.6%) 
0       
(0.0%) 
0    
(0.0%) 
3 
(14.3%) 
1  
(4.8%) 
17  
(81%)* 
12 
(57.1%)** 
15 
(71.4%)* 
- 
0  
(0.0%) 
0       
(0.0%) 
1   
(1.3%) 
5     
(6.6%) 
0     
(0.0%) 
0   
(0.0%) 
25 
(32.9%) 
27 
(35.5%) 
1   
(1.3%) 
0     
(0.0%) 
2   
(2.6%) 
7  
(9.2%) 
35 
(46.1%)* 
4  
(5.3%)** 
25  
(32.9%)* 
A (+) = class 1 integron present; (-) = class 1 integron absent. 
B CTRX = ceftriaxone; CAZ = ceftazidime; CTX = cefotaxime; CFX = cefoxitin; ATM = aztreonam; AMC = amoxicillin/clavulanic acid; AMP = ampicillin; NAL = nalidixic 
acid; EFX = enrofloxacin; GEN = gentamicin; NEO = neomycin; CHL = chloramphenicol; TET = tetracycline; TMP = trimethoprim and SULFA = sulfonamides.                   
* = P < 0.05; ** = P < 0.01 
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                    Table 2.6. Number and percentage of isolates, within serogroup 
                    (O1, O2 or O78), belonging to phylogenetic group A, B1 or D  
Serogroup 
Phylogenetic 
group N % (95% CI) 
O1 A 7 100.0 (59.0 - 100.0) 
B1 0 0.0  (0.0 - 41.0) 
D 0 0.0 (0.0 - 41.0) 
O2 A 10 31.3 (16.1 - 50.0) 
B1 1 3.1 (0.1 - 16.0) 
D 21 65.6 (46.8 - 81.0) 
O78 A 52 89.7 (78.8 - 96.0) 
B1 0     0.0  (0.0 - 6.0) 
D 6   10.3 (3.9 - 21.0) 
 
4. Discussion 
A selection of 97 APEC strains was assessed; these strains were tested for their susceptibility 
to different antibiotics and five active ingredients often included in disinfectants in the poultry 
industry. Resistance to AMP (35.1%), NAL (38.1%), SULFA (41.2%) and TET (53.6%) was 
high, but resistance to relative new antibiotics like second and third generation cephalosporins 
or monobactams was absent or very low, nevertheless, two ESBL producers were found. 
ESBLs are highly present in broilers in Belgium (Smet et al., 2008). Resistance percentage for 
E. coli isolates from septicemia affected laying hens (n = 122) in Switzerland for AMP, NAL, 
SULFA en TET were 11%, 13%, 26% and 26%, respectively (Lanz et al., 2003), which is 
lower than the resistance percentages found in this study. In contrast, clinical APEC isolates 
from laying hens (n = 121) in Iran showed 100% resistance against TET, 96.69% against 
NEO, 76.85% against CHL and 45.45% against GEN (Salehi and Ghanbarpour, 2010). The 
variable resistance prevalence of clinical APEC isolates from laying hens worldwide is 
possibly due to different antibiotic practices in the different countries. In Belgium AMP, TET, 
TMP + SULFA as well as amoxicillin and tylosin are often used to treat APEC affected 
chickens (Persoons et al., 2012; Vandemaele et al., 2002), but nothing is known about the use 
of antibiotics during rearing in laying hens in Belgium. Resistance against TET and TMP + 
SULFA was respectively 66% and 50% for APEC strains (n = 186) from Belgian poultry 
isolated in 2000 (Vandemaele et al., 2002), while in this study percentages of 53.6% and 
15.5% were found. The lower resistance percentage can be explained by the fact that during 
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this study only isolates from laying hens were analyzed. Resistance percentage of 49.5% 
(NAL), 65.8% (SULFA) and 48.1% (TET) were found for AFEC isolates from broilers in 
Belgium (Smet et al., 2008), showing the higher resistance prevalence in broiler isolates 
compared to laying hen isolates, most probably due to higher antibiotic use in broilers. 
Different methods are available for the determination of inhibiting concentrations for 
disinfectants, explaining differences in MICs. Previously, MICs of QAC (59 µg/ml), FOR 
(156 µg/ml), GLU (3250 µg/ml) and H2O2 (2505 µg/ml) were determined for E. coli ATCC 
strain 25922 via broth dilution (Mazzola et al., 2009). During this study MICs of 16 µg/ml 
(QAC), 40 µg/ml (FOR), 1920 µg/ml (GLU) and 64 µg/ml (H2O2) were found for ATCC 
25922, respectively. The difference in MICs is probably due to the use of a different method 
for determining the MICs and the use of a different medium (TSB (tryptone soya broth) 
instead of MHB) and inoculation size. The higher divalent cation concentrations in TSB have 
an influence on certain disinfectants such as QAC, since they will react with the disinfectant, 
decreasing the bactericidal potency (Chambers et al., 1955; Ridenour and Armbruster, 1948). 
Furthermore, a larger inoculation size of ATCC 25922 was used in the experiment from 
Mazolla et al. (2009), probably resulting in a higher MIC. This shows the need for a 
standardized method for determining MICs and MBCs of disinfectants in order to be able to 
compare them. Despite that fact, the relative order of activity of the disinfectants was similar 
(QAC > FOR > H2O2 > GLU). However, it should be noted that MICs of GLU via the agar 
and broth dilution are probably overestimated, due to inhibition of GLU with constituents in 
the media, leaving less compound available to react with the bacteria (Gorman et al., 1980; 
Russell, 1994).  
MICs of H2O2 via the agar and broth dilution method were the same for most strains, namely 
64 µg/ml. While MICs of GLY via the broth dilution method were in general a factor 2 higher 
than the MICs via the agar dilution method. MICs of FOR and GLU on the other hand were a 
factor 2 higher via the agar dilution method than via the broth dilution method, while the 
MICs of QAC were a factor 4 higher via the agar dilution method. This implies that inhibitory 
concentrations via the two different methods are not the same, the agar dilution method gave a 
higher MIC in most cases. This can be due to a faster inactivation of the disinfectant in agar 
(due to interaction with medium components) leading to lower MICs. These results show that 
MICs determined via the two different methods cannot be compared directly. MBCs 
determined via the broth microdilution method were in general the same as the MICs via the 
broth microdilution method, showing that the disinfectants are bactericidal.  
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The MIC and MBC of the different disinfectants had an unimodal distribution over the 
concentrations (see Figure 2.1). This indicates that there was no acquired resistance for any of 
the disinfectants. Little is known about the genetic background of resistance of E. coli to 
disinfectants, only the resistance against QAC has been described. It has been shown that this 
is encoded by the qacE or qacEΔ1 gene, which is present in class 1 integrons (Paulsen et al., 
1993) or via upregulation of the chromosomally encoded multidrug efflux pumps (Poole, 
2005). In this study, 21.6% of the strains were found positive for intl1, while during earlier 
studies, intl1 (or either the complete integron 1) was detected in, respectively, 59.2%, 66.0%, 
and 68.0% of clinical APEC isolates, obtained from the organs of avian species (chicken, 
quail, ostrich, and turkey) (Bass et al., 1999; Goldstein et al., 2001; Yang et al., 2004). The 
presence of qac genes has been shown not to be associated with differences in MICs in Gram-
negative bacteria (Jaglic et al., 2012; Kücken et al., 2000), though it has been shown for  
Staphylococcus aureus that the presence of the qac genes was associated with an elevated 
mode MIC (but not an increased MBC) to chlorhexidine and benzalkonium chloride 
compared to strains not having the qac genes (Furi et al., 2013). However, Smith et al. (2008) 
earlier found an increased MBC for biocides containing QACs and chlorhexidine gluconate 
when Staphylococcus aureus contained qac genes. 
More sensitive methods are necessary to be able to discriminate between susceptible and 
resistant strains. Therefore, first of all a clear definition between reduced susceptible 
(increased MIC) and resistant (not active at in-use concentration) is necessary, as well as a 
more sensitive method (Maillard et al., 2013). Using MBCs instead of MICs might be a step 
in the right direction, since this reflects the concentration at which the biocide kills. 
Furthermore, working with molarity instead of weight/volume might provide part of the 
solution, since this corrects for the weight of the disinfectant. 
A significant relation was found for the presence of class 1 integrons and resistance to 
TMP, SULFA and TET. TMP and SULFA are known to be directly linked to class 1 
integrons, while this is not the case for TET (Marchant et al., 2013; White et al., 2001). 
Genetic linkage between integrons and conjugative plasmids and transposons is a plausible 
explanation (White et al., 2001). 
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No significant differences could be found in integron presence and phylogenetic group 
affiliation, which is in agreement with previous studies (Koczura et al., 2013; Marchant et al., 
2013; Skurnik et al., 2005). It has been shown before that most APEC isolates fell into ECOR 
group A and B2 (Ewers et al., 2009; Ewers et al., 2007) or A and D (Rodriguez-Siek et al., 
2005a). During this study most isolates were classified to group A (71.1%), followed by 
group D (27.8%), while none of the strains belonged to group B2, which is known to contain 
highly pathogenic human (and animal) ExPEC strains (Clermont et al., 2000; Ewers et al., 
2007; Moulin-Schouleur et al., 2007; Rodriguez-Siek et al., 2005a). 
In conclusion, the prevalence of antimicrobial resistance in APEC isolates from laying hens 
was high for AMP, NAL, SULFA, and TET, but low resistance percentages were detected for 
the other tested antibiotics. No phenotypic resistance was observed for the strains to 
disinfectants frequently used in the poultry industry, though the presence of integrons 
indicates the presence of qac resistance genes. A positive association between presence of 
integron class 1 and resistance to TMP, SULFA and TET was found. MICs determined via the 
broth and agar dilution method cannot be compared directly, since different concentrations 
were found for the strains, showing the need for one standardized method for determining 
MICs and MBCs. 
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Abstract 
Once poultry farms are infected with APEC it is hard to eradicate these pathogens. This might 
be due to biofilm formation of APEC strains, hampering cleaning and disinfection practices.  
In this chapter, biofilm formation of APEC strains from laying hens was tested on materials 
used in poultry houses. The strains were analyzed for an association between biofilm-forming 
capacity and O-serogroup. The efficacy of two routinely used disinfectants, H2O2 and a QAC, 
to kill sessile cells of two strong APEC biofilm producers (05/503 and 04/40) and a non-
biofilm producer (05/293) on a polystyrene (PS) and polyvinyl chloride (PVC) surface was 
tested. 
Most APEC strains were moderate (PS) or strong biofilm producers (polypropylene (PP) and 
PVC). Strains of serogroup O2 belonged significantly more often to the moderate (PS) and 
strong biofilm producers (PP and PVC) than to any of the other groups, while most O78 
strains were weak biofilm producers. However, O78 strains were stronger biofilm producers 
on stainless steel than on PP and PVC, while O2 strains were stronger biofilm producers on 
PP and PVC. A dilution of 1% H2O2 was able to kill all sessile cells of strains 05/503 and 
04/40 that adhered to PP and PVC, while 0.5% H2O2 was sufficient to kill all adhering cells of 
strain 05/293. QAC at a concentration of 0.01% killed all adherent cells of strains 05/503, 
04/40 and 05/293 under equal conditions. In conclusion, biofilm formation of APEC strains 
was affected by serogroup and surface material, while biofilm destruction was dependent on 
the disinfectant and surface material. 
 
1. Introduction 
Biofilms form an important obstacle during cleaning and disinfection practices in poultry 
houses. In the all-in all-out system, cleaning and disinfection is normally performed between 
different flocks in the barn, in order to lower the level of specific pathogens (Moustafa Gehan 
et al., 2009). However, little is known about their capacity to form biofilms on different 
materials used in the poultry house. 
It is known that biofilm formation of APEC is dependent on many factors, such as medium 
and phylogenetic group. Nutrient deficient media in general induce biofilm formation 
(Skyberg et al., 2007). Several non-pathogenic E. coli and intestinal pathogenic E. coli strains 
have been analyzed for biofilm formation on several surface structures (Pratt and Kolter, 
1998; Prigent-Combaret et al., 2000; Ryu and Beuchat, 2005; Ryu et al., 2004b; Vidal et al., 
1998). The efficacy of routinely used disinfectants to eradicate APEC biofilms has not much 
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been studied, although it is known for E. coli that formation of a biofilm can hamper 
disinfectant efficacy (Ntsama-Essomba et al., 1997; Ryu and Beuchat, 2005; Somers et al., 
1994).  
In this chapter, we therefore analyzed the capacity of clinical APEC strains to form biofilms 
on PP, PS, PVC and stainless steel. Furthermore, two disinfectants routinely used in poultry 
houses (H2O2 and a QAC) were tested for their ability to kill cells in biofilms. 
 
2. Material and methods 
2.1. Bacterial strains, media and growth conditions 
APEC strains (n = 93) were isolated on 49 different farms from caged laying hens suffering 
from colibacillosis, between the year 2000 - 2005. The APEC strains were serotyped and 
belonged to serogroups O1 (n = 7), O2 (n = 30) and O78 (n = 56) (see Chapter II). LB and 
phosphate buffered saline (PBS) were prepared as described elsewhere (Sambrook et al., 
1989). Bacteria were routinely grown at 37°C, unless stated otherwise.  
2.2. Disinfectants 
Two of the five active ingredients, described in Chapter II, most included in routinely used 
commercial disinfectants in the poultry industry were selected: a QAC (50%; Sigma-Aldrich) 
and H2O2 (42.1 % wt/vol in H2O; EcoClearProx®, ABT Belgium BVBA). H2O2 was selected 
due to its biodegradable character and broad-spectrum antimicrobial activity, QAC for its low 
toxicity, non-corrosive character and low cost. 
2.3. Biofilm formation 
2.3.1. Polystyrene, polypropylene and polyvinyl chloride plates 
A protocol was modified from previous studies (Merritt et al., 2005; O'Toole et al., 1999; 
Skyberg et al., 2007; Stepanović et al., 2004). Briefly, the strains were grown in LB for ≈ 16 h 
in an incubator shaker (230 rpm; Innova 4200), thereafter cultures were diluted 1: 100 (v/v) in 
nutrient deficient media, namely 1/20 diluted TSB (CM0129, Oxoid N.V.) in distilled water 
(DW). The diluted cultures (200 µl) were seeded in the wells of sterile 96-well PS (BD 
Biosciences, Erembodegem, Belgium), PP (VWR International, Leuven, Belgium) and PVC 
(Pittsburgh Corning Europe, S.A.) microtiter plates. PP and PVC materials are used for the 
flooring and water distribution system/automatic drinkers in the poultry house. The strains 
were tested in triplicate per plate over three different plates. The wells on the outside of the 
plate were not used to prevent contamination and evaporation. During a preliminary study, 
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APEC strains 05/503 (O78; PS), 05/39 (O2; PP) and 04/40 (O1; PVC) were shown to be 
strong biofilm producers and APEC strain 05/293 (O78) a non-biofilm producer. These 
strains were added in triplicate to every plate as positive control and negative control strains,
respectively. The plates were incubated for 24 h at 25°C. 
2.3.2. Stainless steel 
Seventeen of the 93 APEC strains were tested for biofilm formation on stainless steel (type 
316; Metaleuven, Wilsele, Belgium), a material used in water distribution systems. The 17 
strains were selected based on a division over the various serogroups and biofilm formation 
capacity on PS, PP and PVC, since not all strains could be tested due to the high workload. 
The 17 APEC strains belonged to serogroups O1 (n = 2), O2 (n = 6) and O78 (n = 9). 
Stainless steel coupons (SSCs) with a diameter of 10 mm were obtained by notching a 
stainless steel sheet (thickness: 3 mm). The SSCs were cleaned, disinfected and autoclaved. In 
each well of a 24-well tissue culture plate (VWR International) a SSC was placed and 500 µl 
of the 1: 100 diluted cultures in nutrient deficient media were added in triplicate to the wells 
and incubated for 24 h at 25ºC. The strains were tested over three different plates. Positive 
control strain 05/503 and negative control strain 05/293 were added in triplicate to every 
plate. 
2.3.3. Quantification of biofilm formation 
Biofilm formation was measured after incubation of the diluted cultures for 24 h in diluted 
TSB (see 'polystyrene, polypropylene and polyvinyl chloride plates'). First the plates/SSCs 
were washed three times with sterile PBS, next they were air dried and the biofilms were heat 
fixed at 60°C for 60 min. The biofilms were stained with crystal violet (0.1% in DW; 200 µl 
per well) at room temperature (RT) for 30 min. Next, the plates were washed three times 
under running DW (washing of SSCs was performed in three separate Falcon tubes containing 
DW). The plates/SSCs were air dried and a mixture of 80: 20, ethanol: aceton (plates: 200 µl; 
SSCs: 500 µl) was added to the wells of the microplates for destaining and incubated for 20 
min at RT. Part of the solution (150 µl) was transferred to a new microtiter plate and the 
optical density (OD) was measured at 540 nm with a microplate reader (Victor2™ 1420-012, 
PerkinElmer, Zaventem, Belgium). 
The strains were classified according to their capacity to produce a biofilm under the 
described conditions, according to a slightly adjusted earlier described method (Stepanović et 
al., 2004). Therefore the average OD540 of the negative control strain (05/293) plus three times 
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the standard deviation (SD) (two times the SD for SSCs) from the mean was calculated for the 
three replicates per plate, in order to get the cut-off OD (ODc) per plate. The average OD540 of 
the strains for the three replicates per plate was calculated and the following scheme was 
used: (1) non-biofilm producer: ODc > OD; (2) weak biofilm producer: (2 x ODc) > OD > 
ODc; (3) moderate biofilm producer: (4 x ODc) > OD > (2 x ODc); and (4) strong biofilm 
producer: OD > (4 x ODc). Three biofilm capacities per strain were obtained and the most 
prevalent capacity was selected. 
2.4. Biofilm cell killing with H2O2 and QAC 
APEC strains 05/503, 04/40 and 05/293 were grown for 24 h in 12 wells/strain for each plate 
type; PS (200 µl) and PVC (150 µl). The plates were washed three times with sterile PBS (PS: 
220 µl, PVC: 200 µl). Two-fold serial dilutions of H2O2 (2%, 1%, 0.5%) and QAC (0.02%, 
0.01%, 0.005%) in saline, as well as plain saline, were added to each well in triplicate (200 µl 
for PS; 150 µl for PVC) and incubated for 30 min at RT. Each plate was washed with sterile 
PBS (PS: 220 µl, PVC: 200 µl per well), then sterile PBS was added to each well (PS: 200 µl, 
PVC: 150 µl per well) and the plates were covered with a sterile film. Plates were sonicated 
for 3 min in a water bath sonicator (Branson 2210, VWR International), the PBS was 
transferred to Eppendorf tubes and ten-fold dilutions were plated in duplicate on LB agar. The 
plates were incubated for 24 h, then bacterial numbers, expressed as cfu/well were 
determined. 
2.5. Confirmation of the biofilm matrix 
To confirm the results found by crystal violet staining and quantification of cells in an 
untreated 24 h biofilm, adhering cells on PS were stained with wheat germ agglutinin-Alexa 
fluor 488 (WGA), according to a previously described method (Burton et al., 2007). APEC 
strains 05/503 and 04/40 (strong biofilm producers) and 05/293 (non-biofilm producer) were 
first grown for 24 h (see 'polystyrene, polypropylene and polyvinyl chloride plates') in a PS 
microtiter plate. All strains were tested in 18-fold, in six-fold per plate repeated over three 
different plates. Plain 1/20 diluted TSB was used to derive the background value. Plates were 
washed twice with sterile PBS, and adhering cells were stained with 200 µl WGA (5 µg/mL; 
VWR International), then washed and destained as described by Burton et al. (2007). 
Emission of WGA was measured at 535 nm after excitation at 485 nm using a multilabel 
microplate reader (Victor2™ 1420-012, PerkinElmer). Average fluorescent readings per plate 
were corrected for the average background value (1/20 diluted TSB) per plate. 
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2.6. Statistics 
The OD540 values of the positive and negative control strains on crystal violet staining were 
analyzed for a normal distribution with Analyse-it (Analyse-it Software, Ltd.) in Microsoft 
Excel (2010). The WGA fluorescent measurements per strain were analyzed for significant 
differences between multiple groups with the Kruskal-Wallis test and between each pair of 
groups with the Wilcoxon Rank Sum Test. 
The chi-square test was used to analyze significant differences between biofilm-forming 
capacity of strains within serogroup (O1, O2 or O78). P ≤ 0.05 was considered significant. 
 
3. Results 
3.1. Influence of surface materials on biofilm formation 
The APEC strains were tested for their biofilm-forming capacity on PS, PP and PVC in 
nutrient deficient medium at 25°C, as this temperature generated stronger biofilm formation 
than 20, 30 and 37°C (data not shown). Results of biofilm formation of the tested APEC 
strains, determined by crystal violet staining, are given in Table 3.1. OD540 values of the 
control strains (05/503 and 05/293) had normal distributions for each material tested. 
On PS, 6/93 strains (6.5%) were non-biofilm producers, 28/93 (30.1%) were weak biofilm 
producers, 42/93 (45.2%) were moderate biofilm producers and 17/93 (18.3%) were strong 
biofilm producers. Strains from serogroups O2 belonged significantly more often to the 
moderate biofilm producers than to the non-, weak or strong biofilm producers (P < 0.05), 
while O78 strains were significantly more often classified as weak or moderate biofilm 
producers (39/56, 69.6%) than as a non- or strong biofilm producers (17/56, 30.4%). 
On PP, 13/93 (14.0%) strains were non-biofilm producers, 23/93 (24.7%) strains were weak 
biofilm producers, 18/93 (19.3%) were moderate biofilm producers and 39/93 (41.9%) were 
strong biofilm producers. Within the O1 serogroup, strains were uniform strong biofilm 
producers and, within serogroup O2, strains were significantly more often classified as a 
strong biofilm producer, than as a non-, weak or moderate biofilm producer (P < 0.05). Most 
O78 strains were weak (20/56, 35.7%) biofilm producers, although there were no significant 
differences in biofilm formation within serogroup O78. A significantly higher percentage of 
strains from serogroups O1 and O2 were classified as strong biofilm producers than strains 
from serogroup O78 (P < 0.05), while a significantly higher percentage of strains from 
serogroup O78 were classified as non- or weak biofilm producers than strains from serogroup 
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O2 (P < 0.05; there were no significant differences from serogroup O1 due to the low number 
of strains tested). 
On PVC, 8/93 (8.6%) strains were non-biofilm producers, 24/93 (25.8%) strains were weak 
biofilm produces, 20/93 (21.5%) strains were moderate biofilm producers and 41/93 (44.1%) 
strains were strong biofilm producers. Six out of seven (85.7%) O1 strains were strong 
biofilm producers. O2 strains belonged significantly more often to the strong biofilm 
producers than to any of the other groups (P < 0.05), while there were no significant 
differences in biofilm formation of strains within serogroup O78. A significantly higher 
percentage of strains from serogroups O1 and O2 were classified as strong biofilm producers
than strains from serogroup O78. 
 
            Table 3.1. Number and percentage of APEC isolates from different serogroups in      
            relation to their capacity to form biofilms on various materials 
Serogroup 
(number of 
isolates) 
Materiala 
Biofilm producer % 
  Non            Weak        Moderate        Strong 
O1 (7) 
PS 14.3 14.3 42.9 28.6 
PP   0.0 14.3   0.0 85.7 
PVC 14.3   0.0   0.0 85.7 
O2 (30) 
PS   0.0A 23.3A 63.3B 13.3A 
PP   0.0A   6.7A 23.3A 70.0B 
PVC   0.0A 10.0A 23.3A 66.7B 
O78 (56) 
PS 10.7A 35.7B 33.9AB 19.6AB 
PP 25.0 35.7 17.9 21.4 
PVC 14.3 37.5 21.4 26.8 
Total (93) 
PS   6.5A 30.1BC 45.2C 18.3AB 
PP 14.0A 24.7AB 19.3A 41.9B 
PVC   8.6A 25.8B 21.5AB 44.1C 
              aTested materials, PS = polystyrene; PP = polypropylene; PVC = polyvinyl chloride 
         Different capital letters show significant differences within the row (P < 0.05). 
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The results for biofilm formation of 17 selected APEC strains on SSCs are presented in Table 
3.2. Eight of these 17 (47.1%) strains were non- or weak biofilm producers on PS and PP, 
while 7/17 (41.2%) strains were non- or weak biofilm producers on PVC. On SSCs, 7/17 
(41.2%) strains were classified as non- or weak biofilm producers, while 10/17 (58.8%) 
strains were moderate to strong biofilm producers. O78 strains were stronger biofilm 
producers on SSC than on PP or PVC (P > 0.05), while more O2 strains were moderate or
strong biofilm producers on PP and PVC than on SSC (P > 0.05). 
 
    Table 3.2. Selection of APEC isolates divided over serogroup in relation to their capacity               
     to form biofilms on stainless steel in comparison with other materials 
Serogroup 
(number of 
isolates) 
Materiala Biofilm producer (number of isolates) 
  Non/weak Moderate/strong 
O1 (2) 
PS 1 1 
PP 0 2 
PVC 0 2 
SSC 0 2 
O2 (6) 
PS 1 5 
PP 0 6 
PVC 0 6 
SSC 2 4 
O78 (9) 
PS 6 3 
PP 8 1 
PVC 7 2 
SSC 5 4 
Total (17) 
PS 8 9 
PP 8 9 
PVC 7 10 
SSC 7 10 
        aTested materials, PS = polysterene; PP = polypropylene; PVC = polyvinyl chloride; SSC = stainless steel  
     coupon. 
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3.2. Biofilm cell killing with H2O2 
Results are given in Figure 3.1. On PS, 622 × 103 and 592 × 103 cfu/well of the strong biofilm 
producer strains 05/503 and 04/40 adhered, respectively, while 5.9 × 103 cfu/well was found 
for non-biofilm producing strain 05/293. After treatment of the biofilms with 0.5% H2O2 for 
30 min, the concentration dropped to 2.5 × 102 and 2.6 × 102 cfu/well for APEC strains 
05/503 and 04/40, respectively, while no culturable/viable cells could be obtained from the 
wells inoculated with strain 05/293. After treatment of the biofilms with 1% H2O2 no 
culturable/viable cells could be detected anymore. 
On PVC, 51 × 103 and 1170 × 103 cfu/well were found for strains 05/503 and 04/40, 
respectively, while for strain 05/293 19 × 103 cfu/well was found. After treatment with 0.5% 
H2O2 for 30 min, 1.4 × 101 and 7.5 × 101 cfu/well were detected for strains 05/503 and 04/40, 
respectively, while no viable cells could be detected for strain 05/293. After treatment with 
1% H2O2 no viable cells were detected in any of the biofilms. 
3.3. Biofilm cell killing with QAC 
Results are presented in Figure 3.2. On PS, 632 × 103 and 395 × 103 cfu/well were found for 
strains 05/503 and 04/40, respectively, while 17 × 103 cfu/well was found for strain 05/293. 
After addition of 0.005% QAC for 30 min at RT, the viable cells counts of strains 05/503, 
04/40 and 05/293 dropped to 28.5 × 103, 1.6 × 103 cfu/well and 0.2 × 102 cfu/well, 
respectively. After addition of QAC to 0.01% no culturable/viable cells could be obtained. On 
PVC, 166 x 103 and 182 × 103 cfu/well were found for strains 05/503 and 04/40, respectively. 
These dropped to 13.1 and 122 cfu/well after addition of 0.005% QAC for 30 min at RT. For 
strain 05/293 33 × 103 cfu/well was detected, which dropped to 3.6 cfu/well after treatment 
with 0.005% QAC, while 0.01% QAC killed all culturable/viable cells that adhered to the 
surface for all tested strains.  
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Figure 3.1. Viable cell quantification after treatment of adhering cells with hydrogen peroxide. 
Adhering cells of strong biofilm producer strains (05/503 and 04/40) and a non-biofilm producer strain (05/293) 
were treated with two-fold dilutions of H2O2, after incubation for 24 h. Viable cell numbers were quantified 
(cfu/well). A) polystyrene surface; B) polyvinyl chloride surface. 
H2O2 = hydrogen peroxide. 
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Figure 3.2. Viable cell quantification after treatment of adhering cells with a quaternary 
ammonium compound. Adhering cells of strong biofilm producer strains (05/503 and 04/40) and a non-
biofilm producer strain (05/293) were treated with two-fold dilutions of a quaternary ammonium compound, 
after incubation for 24 h. Viable cell numbers were quantified (cfu/well). A) polystyrene surface; B) polyvinyl 
chloride surface. QAC = quaternary ammonium compound.  
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3.4. Presence of a biofilm matrix 
Biofilms were stained with WGA to confirm the presence or absence of a biofilm matrix. 
Strains 05/503 and 04/40 had a significantly higher average fluorescence intensity than strain 
05/293 (P < 0.0001), indicating that strains 05/503 and 04/40 formed a biofilm matrix, while 
strain 05/293 did not (Fig. 3.3). This is in agreement with the results found with crystal violet 
staining and the number of adhering cells found on PS. The highest numbers of viable cells 
was found for strain 05/503, followed by strains 04/40 and 05/293. 
   
                                   
 
Figure 3.3. Fluorescence intensity of adhering APEC cells to polystyrene microplates. 
Two strong biofilm producer strains (05/503 and 04/40) and a non-biofilm producer strain (05/293) stained with 
WGA, after growth for 24 h on a polystyrene surface. Average values of three independent measurements 
(performed in six-fold per plate) are shown with the standard deviations. 
a.u. = arbitrary units 
*** P ≤ 0.0001 
 
4. Discussion 
Most APEC strains formed moderate biofilms on PS, while a substantial biofilm was formed 
on PP and PVC under nutrient deficient conditions at an environmental temperature of 25ºC. 
This is important, since these environmental conditions can be encountered in the poultry 
houses, especially in the water systems and automatic drinkers were PP and PVC materials 
are used. β-1,6-N-acetyl-d-glucosamine is an important sugar for binding to abiotic surfaces, 
cell-to-cell binding and actual biofilm formation of E. coli (Wang et al., 2004). Enzymatic 
hydrolysis of β-1,6-N-acetyl-d-glucosamine leads to the disruption of the integrity of the 
biofilm (Itoh et al., 2005). We showed that non-biofilm producer strain 05/293 had indeed a 
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significantly lower average fluorescence intensity than strong biofilm producer strains 05/503 
and 04/40, after staining with WGA. Even though strain 05/293 is a non-biofilm producer, ≈ 
104 cfu/well adhered to PS, which is only 2 logs lower than cell concentrations of strains 
05/503 and 04/40, while on PVC ≈ 3 × 104 cfu/well was found for strain 05/293, only 0.5 - 2 
logs lower than for strains 05/503 and 04/40 (see Figure 3.1 and 3.2). The negative control 
strain probably forms a monolayer of cells with no intercellular binding and formation of an 
elaborate network, as indicated by weak WGA staining.  
Serogroup O2 strains were more often classified as strong biofilm producers on PP and PVC 
than as non-, weak or moderate biofilm producers (P < 0.05). They were mostly moderate 
biofilm producers on PS. The same trend was found for the O1 strains on PP and PVC, 
although not significant due to the low number of tested strains. Most O78 strains were weak 
biofilm producers on PP and PVC. The O78 strains might have a more hydrophilic 
polysaccharide side-chain than the O1 and O2 strains, due to their different composition of the 
LPS (Stenutz et al., 2006), making it harder to overcome the repulsive force of the 
hydrophobic nonpolar abiotic surface. These results are supported by the finding that more 
O78 were moderate or strong biofilm producers on SSCs, than on the more hydrophobic 
materials (PP and PVC). Fewer O2 strains were moderate or strong biofilm producers on 
SSCs than on the other materials. However, due to the low number of tested strains no 
statistical differences could be found.  
Different culture conditions (O2 concentration, temperature, medium) have a consequence on 
biofilm-forming capacity, as already shown by Skyberg et al. (2007) for APEC strains grown 
in various media. In our study, APEC cultures in the stationary growth phase were seeded in 
diluted TSB, since this nutrient-depleted medium promotes biofilm formation (Skyberg et al., 
2007). However, seeding bacterial cultures in specific minimal media may give an even more 
precise estimation of the environmental conditions in a poultry house. Since the aim of our 
study was to define differences between serogroups, optimal conditions for biofilm formation 
were used for easier recognition of differences.  
A dilution of 1% H2O2 was effective in killing all cells of strains 05/503 and 04/40 that 
adhered to a PS and PVC surface, while 0.5% was sufficient to kill all adhering cells of strain 
05/293. A concentration of 0.01% QAC, on the other hand, was already effective in 
eradicating all sessile cells for the tested strains. In-use concentrations of QAC in the poultry 
house range between 400 - 1.500 µg/mL (0.04% - 0.15%) and for H2O2 between 420 - 50.400 
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µg/mL (0.042% - 5.4%). The in-use concentrations for QAC are higher than the obtained 
concentrations needed to kill the sessile cells during our study, while the obtained 
concentration for H2O2 is higher than the lowest in-use concentration and lower than the 
highest in-use concentration. It should be realized that our biofilms are relatively young. 
Older biofilms may have a more elaborate network, whereby the effectiveness of the 
disinfectants will most likely be impaired to a greater degree, as shown with some food-borne 
bacteria (such as Listeria monocytogenes and Salmonella spp.) (Corcoran et al., 2014; Lee 
and Frank, 1991; Mangalappalli-Illathu et al., 2008). Moreover, the presence of organic 
matter in the poultry house can inhibit the effectiveness of disinfectants, usually leaving less 
compound available to react with the microorganisms. Nevertheless, concentrations of 2-3% 
H2O2 had good antimicrobial activities in the presence of organic matter in a poultry house, 
QACs were affected to a greater degree (Moustafa Gehan et al., 2009).  
H2O2 and QAC were more effective in killing adherent cells on PVC than PS. The higher 
effectiveness of the tested disinfectants on PVC shows that the surface material should also be 
considered in the choice for and concentration of disinfectant. However, this is of course not 
the only selection criterium for the choice of a certain disinfectant, also economic reasons and 
the characteristics of the disinfectants play a major role. Unfortunately, the biofilm cell killing 
on SSCs was not tested in this study due to the high workload. It is difficult to compare the 
obtained disinfectant concentrations necessary to kill the sessile cells in our study with 
previously found results, because of the existence of several different testing methods, 
showing the need for one standardized international method. 
In conclusion, under the tested conditions most APEC strains were moderate to strong biofilm 
producers on materials used in poultry houses, such as PP and PVC. Within the serogroups, 
significant differences could be found in biofilm-forming capacity of the strains. A dilution of 
1% H2O2 was capable of killing all cells of strong biofilm producer strains 05/503 and 04/40 
on a PS and PVC surface, while 0.5% H2O2 was sufficient to kill all cells of a non-biofilm 
producer strain. A dilution of 0.01% QAC was already sufficient to kill all cells in the biofilm 
of the strong and non-biofilm producing strain. 
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Abstract 
In this chapter, the nebulization of low concentrations of H2O2 was tested in the presence of 
chickens to reduce infection pressure. However, significantly higher lesion scores and higher 
E. coli concentrations were found in the spleen of chickens exposed to 2% H2O2, followed by 
those exposed to 1% H2O2. Control chickens, exposed to DW, had the lowest lesion scores 
and E. coli concentrations in the spleen. Thus, H2O2 is rendering animals more prone to 
APEC infection, contraindicating H2O2 nebulization in the presence of chickens. 
 
1. Introduction 
Sanitation and cleaning is a first way to reduce infection pressure (Moustafa Gehan et al., 
2009), but is normally performed between different flocks in the barn to prevent flock to flock 
transmission. The information about the use of disinfectants in the presence of animals to 
lower infection pressure and prevent APEC is limited. On conditions safe to the animals, 
nebulization of H2O2 in the presence of chickens may possibly lower infection pressure, since 
(pathogenic) E. coli is normally present in high concentrations in the barn in the form of 
faeces-contaminated dust (Barnes et al., 2008; Dho-Moulin and Fairbrother, 1999; Dziva and 
Stevens, 2008). Predisposing factors, such as viral live vaccines, render chickens more prone 
to APEC infection (La Ragione and Woodward, 2002; Nakamura et al., 1994). Several studies 
on H2O2 toxicity have been performed on rats, mice, rabbits and dogs, but there is no 
documentation on such studies in chickens. As toxicity is depending on many factors like 
exposure time, number of exposures and concentration (Anonymous, 2003), the goal of this 
chapter was to test if H2O2 nebulization in the presence of chickens can lower infection 
pressure and pathogenicity of APEC. 
 
2. Material and methods 
2.1. In vivo testing of nebulization with H2O2 
The animal experiment was approved by the ethical committee of the KU Leuven (Permit 
Number: P176/2011) and conducted in strict accordance with the Federation of European 
Laboratory Animal Science Associations (FELASA) guidelines. 
Fifteen one-day-old chickens (Ross; Belgabroed NV, Merksplas, Belgium) were housed in a 
disinfected barn and provided with water and feed ad libitum. At four weeks of age, the 
chickens were orally vaccinated against Newcastle disease (106 mean egg infective dose; 
MSD Animal Health, Boxmeer, the Netherlands) to render them subsequently more 
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susceptible to APEC challenge. Three days post vaccination (dpv), the chickens were 
transferred and equally divided over three disinfected isolators. Three and 4 dpv they were 
aerogenically infected with a virulent APEC strain CH2 (Vandemaele et al., 2005) (10 ml of 
1010 cfu/ml) with the help of a compressor (KNF Neuberger, Aarselaar, Belgium) and 
nebulizer (Cirrus 2; Intersurgical, Uden, the Netherlands). The chickens were exposed to the 
aerosols for 60 min. One day thereafter, they were exposed to 10 ml of different H2O2 
concentrations (EcoClearProx®, ABT Belgium BVBA) by nebulization for 60 min (Group 1 - 
2% H2O2; Group 2 - 1% H2O2; Group 3 - DW). 
Eleven dpv all surviving chickens were euthanized by cervical dislocation for clinical 
necropsy. Macroscopic lesions were scored according to Vandemaele et al. (2005). Briefly, 
macroscopic lesions in the left and right thoracic air sac, the abdominal air sacs, the left and 
right lung, liver and heart were each scored from 0 to 2. Intermediate signs for APEC lesions 
were scored between 0.5 and 1.5. Chickens that died or were euthanized because of serious 
clinical APEC symptoms were given the full score (14), after confirming severe APEC 
lesions on necropsy.  
2.2. Bacterial re-isolation from the spleen 
From two or three chickens per group (chickens that had macroscopic lesions) the spleen was 
aseptically removed and homogenized in sterile PBS (1 g of tissue in 1 ml PBS), as described 
before (Tuntufye et al., 2012a). Ten-fold dilutions were plated on MacConkey agar (Oxoid 
CM0115) and incubated at 37ºC for 24 h, after which bacterial numbers (cfu/g) were 
determined. 
2.3. Statistics 
Results were analyzed with SAS software version 9.4 (SAS Institute Cary, North Carolina, 
USA) and R (R Development Core Team, 2013). The sum of the total lesion score and the 
lesion scores per organ were calculated for the three groups. To evaluate the hypothesis of a 
higher total lesion score in infected chickens treated with DW than H2O2, the total lesion 
scores were analyzed by means of an ordinal logistic regression model. Results of ordinal 
logistic regression are presented as the odds ratio of having a high lesion score. Average 
bacterial concentrations were compared using the Kruskal-Wallis Test for significant 
differences between multiple groups and the Wilcoxon Rank Sum Test for differences 
between each pair of groups, since few data were available per group. P ≤ 0.05 was 
considered significant. 
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3. Results 
3.1. Mortality and lesion scores 
Mortality and lesions scores of infected/treated chickens are given in Table 4.1. None of the 
chickens died after infection. Chickens that were exposed to H2O2 had a higher sum of total 
lesion scores (Group 1: 42 and Group 2: 20) than chickens exposed to DW (Group 3: 14). 
Infected chickens treated with 1% H2O2 had a 3.53 (95% CI, 0.30 - 88.84) higher chance of 
developing a high lesion score (score: 14) than infected chickens treated with DW. This 
chance was 12.28 (95% CI, 1.01 - 357.07) higher in infected chickens treated with 2% H2O2
than with 1% H2O2. Thus nebulization of 2% H2O2 does increase the lesion scores. 
 
Table 4.1. Mortality and lesion scores of infected/treated chickens  
     Sum of lesion scores 
Group Infection1 Treatment2 Total3 Deaths4 Liver PRD TAS-L TAS-R LU-L LU-R AAS TOT 
1 CH2 2% H2O2 5 0 6 6 6 6 6 6 6 42A 
2 CH2 1% H2O2 5 0 2 2 4 4 2 2 4 20B 
3 CH2 DW 5 0 2 2 2 2 2 2 2 14B 
1Aerogenic infection with 10 ml 1010 cfu/ml APEC CH2 at 31 and 32 days of age. 
 2Chickens aerogenically treated with 2% H2O2, 1% H2O2 or distilled water, at 33 days of age i.e. 24 h after the 
2nd infection. 
 3Total number of chickens per group.  
 4Total number of chickens that died or were euthanized during the experiment.  
PRD = pericardium; TAS-L = left thoracic air sac; TAS-R = right thoracic air sac; LU-L = left lung; LU-R = 
right lung; AAS = abdominal air sacs; TOT = total lesion score; DW = distilled water.  
Numbers within the same column with different capital letters show significant differences (P ≤ 0.05). 
 
3.2. Bacterial re-isolation from the spleen 
Bacterial numbers (cfu/g) isolated from the spleen in chickens of Group 1, Group 2 and 
Group 3 are shown in Figure 4.1. The highest bacterial load from the spleen was obtained in 
the group of chickens exposed to aerosols of 2% H2O2, followed by 1% H2O2 and DW (P ≈  
0.11). 
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                           Figure 4.1. Isolated bacterial concentrations from the spleen 
2% H2O2: 3 out of 5 chickens had macroscopic lesions (3 spleens with lesions) 
1% H2O2: 3 out of 5 chickens had macroscopic lesions (1 spleen with lesions) 
DW: 1 out of 5 chickens had macroscopic lesions (1 spleen with lesions) 
DW = distilled water, ns = not significant (P ≥ 0.05) 
 
Discussion 
In this chapter, the use of H2O2 nebulization was tested to reduce environmental 
contamination in a chicken house, after nebulization of APEC aerosols. However, 
nebulization of 1% H2O2 and 2% H2O2 did result in an increased total lesion score in 
comparison to nebulization of DW. This worsening effect after H2O2 nebulization is probably 
due to the caustic effect of H2O2 radicals on (ciliated) epithelial cells. Which is also the case 
for Newcastle disease virus infection (or vaccination with virulent vaccines) in one-day-old 
chickens (Mast et al., 2005), making it easier for APEC to cross the upper respiratory tract 
causing colibacillosis. This hypothesis is strengthened by the fact that the highest bacterial 
concentrations were recovered from the spleen of chickens exposed to 2% H2O2, followed by 
1% H2O2 and DW. However, no statistically differences were found between the groups, due 
to the low number of tested animals. Histology coupes of the trachea, as also made by Mast et 
al. (2005) after vaccination of one-day-old chickens with a Newcastle disease vaccine, can 
give more conclusive results.  
Only two concentrations of H2O2 were tested for its effect on mortality, lesion scores and 
concentration of recovered bacteria from the spleen, after exposure to APEC aerosols. 
Possibly lower concentrations of H2O2 could result in lower lesion scores and bacterial 
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concentrations recovered from the spleen. However, lower concentrations were not tested, 
since only three isolators were available. Due to time restrictions a second experiment could 
not be performed.  For future studies it may be useful to test lower concentrations. As toxicity 
was also shown to be dependent on exposure time and number of exposures (Anonymous, 
2003), these parameters should also be taken into consideration.  
The presented results give a good indication that nebulization of H2O2 (higher than 1%) in the 
presence of chickens to reduce infection pressure is not advisable. However, such 
concentrations can be used in an experimental respiratory infection model to predispose the 
chickens to APEC infection.  
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Abstract 
In this chapter, an APEC strain was marked with the luciferase operon (LuxCDABE), using a 
Tn7 transposon, to be able to follow the pathogenesis of APEC infection. 
The sensitivity of the strain was tested for specific phages and an experimental infection was 
executed to determine its virulence. Organs of experimentally infected chickens were tested 
for a correlation between luminescence and the concentration of luminescent bacteria. 
The transposition of the lux operon into the chromosome of the APEC isolate did not affect 
the virulence of the latter strain nor its sensitivity for lytic phages. A correlation between the 
number of bacteria and the luminescent signal was found in vitro in liquid medium, as well as 
in the homogenized heart, liver and lung of four-week-old experimentally infected chickens. 
The transposition of lux was furthermore useful for identification of the infecting strain after 
homogenization and plating of organs from experimentally infected chickens. 
 
1. Introduction 
Different reporter systems are available for monitoring bacterial cells in vivo and ex vivo, of 
which green fluorescent protein (GFP) and its derivatives, bioluminescent enzyme firefly 
luciferase (Luc) and bacterial luciferase (Lux) are some examples. The bacterial luciferase 
operon (lux), however, is the only reporter system that is able to synthesize from endogenous 
material all the substrates required for the production of light (Engebrecht et al., 1983). 
Therefore actively growing cells are necessary, since the functioning of lux depends on 
oxygen, reduced flavin mononucleotide and aldehyde co-substrates. The luciferase reaction of 
Photorhabdus luminescens has a temperature optimum of 40ºC, far higher than other 
identified luciferases (Colepicolo et al., 1989). This temperature is close to the core body 
temperature of chickens (42ºC), and is therefore an interesting reporter system for monitoring 
bacterial infections in these animals. The complete gene operon, consisting of five genes 
(luxCDABE), was successfully expressed in host organisms such as E. coli, Salmonella and 
optimized for Gram-positive bacteria such as Staphylococcus aureus and even eukaryotic 
cells (Engebrecht et al., 1983; Francis et al., 2000; Gupta et al., 2003; Howe et al., 2010). Lux 
labelled Staphylococcus aureus infection in mice could be monitored in real-time, allowing 
the determination of treatment effects in vivo (Francis et al., 2000). Therefore, two strains of 
luminescent Staphylococcus aureus were injected into the thigh muscles of mice, followed by 
either no treatment (control) or treatment of the mice with amoxicillin. Bioluminescence from 
the bacteria in the muscles of the mice was followed using a photon-counting intensified 
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charge-coupled device camera. No signal could be detected anymore in the treated mice 24 h 
post infection, while the untreated groups showed strong bioluminescent signals. A 
correlation between the luminescent bacteria in the thigh muscles and the luminescent signal 
was found.  
In this chapter, the bacterial luciferase operon luxCDABE was chromosomally integrated in an 
APEC strain, using a Tn7 transposon. The detection of the luminescent signal and the 
correlation between the luminescent signal and the concentration of bacteria in the organs was 
optimized to quantify bacteria and monitor the effects of treatment on colibacillosis. 
 
2. Material and methods 
2.1. Bacterial strains, phages and media 
APEC strain CH2 (O78) had been isolated from the heart of a diseased chicken with E. 
coli septicemia (van den Bosch et al., 1993) and was shown to be virulent in chickens 
(Vandemaele et al., 2005). Plasmid pBEN276 (kindly provided by Prof. Dr. Nancy Craig, the 
Johns Hopkins University and the Howard Hughes Medical Institute, USA) was used to 
chromosomally integrate the lux operon CDABE into CH2, according to a slightly different 
protocol as described before (Howe et al., 2010). Non-pathogenic E. coli strain BL21 was 
used as a non-pathogenic control strain (Chart et al., 2000). The phages used during this study 
were: PhAPEC2, PhAPEC5, PhAPEC7 and PhAPEC9. They were isolated from water 
samples, collected from rivers and brooks in and around Brussels (Belgium) in the vicinity of 
poultry houses between the year 2000 - 2010 (Tsonos, 2014). They were all able to lyse 
model strain CH2. Media and growth conditions were as mentioned in chapter II and III, 
unless stated otherwise. Ampicillin was used for recombinant selection and added at a 
concentration of 100 µg/ml. 
2.2. Construction of CH2-lux 
Electrocompetent cells were prepared as described by Sambrook et al. (1989). 
Electrocompetent CH2 cells were transformed with 1 µl pBEN276 by electroporation with a 
Bio-Rad® Gene Pulser Xcell™ (Bio-Rad Laboratories N.V.) at 1.7 kV with 25 μF and 200 Ω. 
Cells were resuspended in freshly prepared super optimal broth with catabolite respression 
(SOC) medium (Sambrook et al., 1989) and grown for 1 h at 30ºC for recovery, whereafter 
the culture was streaked onto ampicillin containing LB agar. Plates were incubated at 30ºC for 
18 h and resistant colonies were picked to perform a colony PCR for the confirmation of a 
successful transformation with pBEN276.  
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Fresh colonies were picked from LB agar, resuspended in 2 µl sterile Milli-Q water. PCR to 
confirm the presence of the lux operon was performed using the following reaction mix: 2.1 
µl buffer, 1.6 µl dNTPs (2.5 mM), 1 µl forward and reverse primer (LuxA-F and LuxA-R, see 
Table 5.1) (10 µM), 0.1 µl Taq enzyme (5 u/µl; SphaeroQ, Leiden, the Netherlands) and 12.2 
µl Milli-Q water. PCR conditions were: 94°C for 5 min (initial denaturation), followed by 35 
cycles of [94°C for 30 s (denaturation), 57.5°C for 1 min (annealing) and 72°C for 1 min 
(elongation)], followed by a final elongation at 72°C for 5 min. PCR products were visualized 
on a 2% agarose gel with Midori Green Advance (1 µl / 20 ml agarose gel; NIPPON Genetics 
EUROPE GmbH, Dueren, Germany) by transillumination with UV light (302 nm). 
Colonies were resuspended in LB medium with various arabinose concentrations (0.01 – 
0.5%) and incubated for 16 h at 30ºC to induce transposition. The cultures were streaked onto 
LB agar and incubated at 42ºC for 16 h to prevent replication of the temperature-sensitive 
plasmid. 
Colonies were picked, resuspended in LB medium and incubated at 42ºC (230 rpm) for 16 h. 
A PCR was conducted with site-specific primers [LuxC-F(int) and GlmS-R(int), see Table 
5.1] to confirm successful transposition of luxCDABE into the CH2 genome. Therefore 1 µl of 
the overnight culture was mixed with 12 µl Milli-Q water, 15 µl KAPA2GTM Robust Hot 
Start Ready Mix (Sopachem, Eke, Belgium) and 1 µl forward and reverse primer (10 µM). 
The following conditions were used: 95°C for 10 min (initial denaturation), followed by 30 
cycles of [95°C for 15 s (denaturation), 60°C for 15 s (annealing) and 72°C for 15 s 
(elongation)]. PCR products were visualized on a 2% agarose gel with Midori Green Advance 
by transillumination with UV light. The products were purified with the GENECLEAN® Kit
(MP Biomedicals, Illkirch Cedex, France) according to manufacture instructions. 
 
       Table 5.1. Oligonucleotides used in this chapter 
Name Sequence (5' to 3') Size (bp) 
LuxA-F TGGTTACTGGAGCATCATTTCAC 
928 
LuxA-R GCATGACATCAGACTGGAAGAG 
LuxC-F(int) ACCTGGCAAAATCGGTAACG  
884 
GlmS-R(int) ACCTGGCAAAATCGGTAACG  
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The purified fragments were sequenced using 3.5 µl PCR-product (100 ng/µl), 3 µl primer (1 
µM), 1 µ Big Dye buffer and 3 µl Big Dye Master Mix (Life Technologies Europe B.V., 
Gent, Belgium) PCR conditions were: 96°C for 1 min (initial denaturation), followed by 30 
cycles of [96°C for 30 s (denaturation), 50°C for 15 s (annealing) and 60°C for 1 min 
(elongation)]. The fragments were purified with ethanol precipitation. The pellet was air-
dried, dissolved in 10 µl HiDiTM Formamide (Life Technologies Europe B.V.) and sequenced 
(ABI PRISM 3100 Genetic Analyzer, Life Technologies Europe B.V.). 
After confirmation of the correct integration of luxCDABE in CH2 by aligning the sequence 
with BLASTN (http://blast.ncbi.nlm.nih.gov) (Altschul et al., 1997), a -80ºC stock culture 
was made in 15% glycerol. 
2.3. Time-lapse of bioluminescence after spiking of homogenized organs with CH2-lux 
and bacteriophages 
The time-lapse of bioluminescence in homogenized organs (2 g in 2 ml PBS) of four-week-
old BL21 infected chickens (see below) was followed after spiking with CH2-lux (109cfu in 
200 µl PBS; t = 0 min) and before and after spiking with CH2-specific lytic phages (109 
plaques forming units (pfu) of all four phages (PhAPEC2, PhAPEC5, PhAPEC7 and 
PhAPEC9) in 200 µl PBS; t = 50 min). The luminescence was analyzed on an IVIS Spectrum 
imaging system (PerkinElmer) using Living Image software 4.3 (PerkinElmer) for a period of 
3 h (measurements with an interval of 5 min). Each individual well containing the 
homogenized organs was manually selected as a region of interest (ROI). The bioluminescent 
signal was measured in photons per second per square centimeter per steradian (p/s/cm2/sr). 
2.4. Correlation between CH2-lux concentration and bioluminescent signal 
A fresh overnight culture of CH2-lux was diluted 1: 100 in LB medium, grown to exponential 
phase (OD ≈ 0.5 - 0.6) and spun down for 15 min at 2,003 × g (4ºC). The pellet was 
resuspended in LB and two-fold dilutions were made in triplicate starting at 6.0 × 107 cfu in 
200 µl LB, whereafter they were added to a black polystyrene microplate with clear bottom 
(Pittsburgh Corning Europe, S.A.). The negative control consisted of plain LB medium. 
Luminescence was measured at 37ºC with the IVIS Spectrum imaging system. Each 
individual well with luminescent bacteria was manually selected as a ROI. The 
bioluminescent signal was measured in p/s/cm2/sr.  
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2.5. Bacteriophage sensitivity of CH2-lux 
CH2-lux was compared with CH2 for its sensitivity to the four specific phages. Ten-fold 
dilutions (20 µl) of the phages were brought on a double agar plate (Adams, 1959) with, 
respectively, CH2-lux and CH2. After incubation for 16 h, the concentration of phages was 
determined (pfu/ml). 
2.6. Virulence of CH2-lux 
To verify whether the virulence of CH2-lux was not affected by lux, different animal infection 
experiments were performed that were approved by the Ethical Committee of the KU Leuven 
(P176/2011). Fifty-five one-day-old chickens (Ross, Belgabroed NV) were housed in a 
disinfected barn, randomly divided over different groups and provided with feed and water ad 
libitum. 
2.6.1. One-day-old chickens 
Ten one-day-old chickens were subcutaneously infected (200 µl 107 cfu/ml) with either CH2-
lux or BL21 (200 µl 107 cfu/ml). At this concentration, CH2 kills 100% of the infected chicks 
(Tuntufye et al., 2013), but was not tested to avoid killing of more chicks. Mortalities were 
monitored till seven days post infection (dpi), to determine the virulence of CH2 after the 
integration of lux. 
Organs of chicks that had acutely died or been euthanized 7 dpi, were aseptically removed 
and were scanned for bioluminescence in a petri dish (spleen, 1/2 lever, lung, heart), using the 
IVIS Spectrum imaging system. The organs were placed in petri dishes and the dishes were 
sealed with Parafilm® in order to prevent contamination of the facility where the camera was 
located. Thereafter the organs were homogenized in PBS (1 g organ in 1 ml PBS) and 
dilutions were plated on LB agar (Tuntufye et al., 2012a). After incubation for 16 h, the 
colonies were checked for luminescence using IVIS and concentrations were determined 
(cfu/g).  
2.6.2. Four-week-old chickens 
Forty-five four-week-old chickens were divided over nine groups that consisted of five 
chickens each. The chickens were housed in the same room, but in different cages. In between 
the cages there was a space of 20 cm, so that the chickens were not in direct contact with each 
other. Chickens were intratracheally infected (with either 106, 107, 108, or 109 cfu of CH2-lux 
or CH2 in 500 µl PBS), as previously described (Tuntufye et al., 2012a). The five chickens in 
the control groups were infected with BL21 (109 cfu in 500 µl PBS). Animals were monitored 
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over a period of 9 dpi, mortalities were scored and chickens that died or were euthanized prior 
to termination of the experiment were necropsied and scored according to the score system of 
Vandemaele et al. (2005). 
2.7. Optimization of bioluminescent signal and detection limit 
Homogenized organs from four-week-old chickens (2 g organ in 2 ml PBS) were transferred 
to a 12-well plate, after which the organs were spiked with ten-fold dilutions (107 to 103 cfu) 
of an exponentially grown CH2-lux culture in LB medium to determine the detection limit of 
luminescence. Each individual well containing the homogenized organs was manually 
selected as a ROI. 
The homogenized liver and spleen from one CH2-lux infected chicken (106 cfu) were diluted 
to determine the effect of dilution on the detectable luciferase signal. Therefore 1 ml of 
homogenized liver and spleen was transferred to a 12-well plate, organ homogenates were 
serially diluted in PBS using two-fold dilution steps. The bioluminescence was measured and 
the increase in detectable luciferase activity was determined. 
 
3. Results 
3.1. Construction of CH2-lux 
All colonies that grew after electroporation on the ampicillin containing LB agar plate were 
successfully transformed with pBEN276 (confirmed with PCR). These colonies were 
resuspended in LB medium containing various arabinose concentrations and streaked onto LB 
agar. Transposition of the lux operon into the attTn7 site of the CH2 chromosome was 
confirmed by PCR and the PCR products of one colony were sequenced and aligned, which 
confirmed the transposition of the lux operon into the attTn7 site (downstream of the glmS 
gene) of the CH2 chromosome. 
3.2. Time-lapse of bioluminescence after spiking of homogenized organs with CH2-lux 
and bacteriophages 
After spiking the homogenized organs with CH2-lux (109 cfu) there was a clear increase in 
luminescence from 7.1 × 102 - 1.4 × 103 p/s/cm2/sr to 7.4 × 104 - 3.2 × 105 p/s/cm2/sr, while a 
clear reduction in luminescence could be seen after spiking with the phage cocktail from 
about 3.0 × 105 p/s/cm2/sr to 1.5 × 104 p/s/cm2/sr for the heart and liver about 2.5 h after 
spiking (t = 180 min). For the lung, the luminescence decreased from 7.4 × 104 to 2.3 × 103 
p/s/cm2/sr and for the spleen from 1.9 × 105 to 5.6 × 103 p/s/cm2/sr (see Figure 5.1). 
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Figure 5.1. Time-laps of luminescence of homogenized organs after spiking with CH2-lux and 
before and after spiking with bacteriophages in a 6-well plate. CH2-lux (109 cfu) was added at t  = 0 
min, while the bacteriophages (109 pfu of every bacteriophage) were added at t  = 50 min. Heart (diamonds), 
liver (squares), spleen (circles) and lung (triangles). 
 
3.3. Correlation between concentration CH2-lux and bioluminescent signal 
A clear linear correlation could be found between the concentration CH2-lux bacteria and 
bioluminescence in LB medium (R2 = 0.98) (see Figure 5.2). The minimum detectable 
concentration of luminescence was 3.2 × 104 cfu in 200 µl LB medium. 
3.4. Bacteriophage sensitivity of CH2-lux 
No significant differences were found in phage concentration (PhAPEC2, PhAPEC5, 
PhAPEC7 and PhAPEC9) between amplification on CH2-lux and CH2 (data not shown), 
which confirms that CH2 after transposition with lux remains equally sensitive to the tested 
bacteriophages. 
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Figure 5.2. Luminescent signal in relation to concentration CH2-lux. Luminescent signal in relation 
to concentration CH2-lux. 10Log values of bacterial numbers relative to 10log bioluminescent units are graphed. 
Average values and standard deviation of three measurements are shown. R2 = 0.98. 
 
3.5. Virulence of CH2-lux 
3.5.1. One-day-old chickens 
Three out of five CH2-lux infected chickens died, while none of the BL21 infected chickens 
died, suggesting that the strain is still virulent after the transposition of the lux operon. The 
organs of the two chickens in the CH2-lux infected group that survived the infection, were not 
luminescent and no luminescent colonies were found after homogenization and plating. One 
chicken in the BL21 group showed clinical signs of APEC infection and although no 
luminescence of the organs was observed, luminescent colonies were detected after 
homogenization and plating (1.9 × 103; 8.0 × 101; 1.7 × 103 and 8.7 × 102 cfu/g in the lung, 
spleen, liver and heart, respectively). Since the chickens were housed together it is plausible 
that contamination between the chickens took place. 
Many non-luminescent colonies were detected, after plating of the homogenized organs from 
the chickens that died or showed clinical signs of infection, especially in the lungs. 
 
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.5
4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0
10
lo
g 
bi
ol
um
in
es
ce
nc
e 
(p
/s
/c
m
2 /s
r)
10log bacterial numbers (cfu)
68 - Chapter V: Bioluminescent APEC for monitoring colibacillosis 
 
 
Figure 5.3. Luminescence of organs of a four-week-old lux-infected chicken (infected with 
107cfu). A) spleen, B) heart, C) liver, D) lung. 
 
3.5.2. Four-week-old chickens 
All chickens infected with CH2-lux (109 cfu) died, while one out of five chickens survived in 
the CH2 group (109 cfu). One chicken in the groups infected with 107 and 108 cfu (CH2-lux 
and CH2) survived, as did three out of five chickens in the 106 cfu infected groups. All 
chickens that died or were euthanized prior to termination of the experiment showed 
macroscopic lesions typical of systemic APEC infection, including airsacculitis, pneumonia, 
pericarditis and perihepatitis and got the maximum lesion score of 14. All chickens that were 
euthanized at termination of the experiment (9 dpi) did not show clinical signs of APEC. 
None of the chickens infected with BL21 died, nor showed clinical symptoms of APEC 
infection and no macroscopic lesions were observed during necropsy at termination of the 
experiment. The results indicate that CH2 remained equally virulent after lux transposition. 
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Figure 5.4. Luminescence of homogenized organs (2 g) in 6-well plates from four-week-old CH2-
lux infected chickens. Upper left: lung, upper right: liver, lower left: spleen, lower right: heart. Chickens 
euthanized: C (infected with 108 cfu); chickens that acutely died: A (infected with 109 cfu), B (infected with 107 
cfu), D (infected with 106 cfu), E (infected with 109 cfu). 
 
3.6. Optimization of bioluminescent signal and detection limit 
The organs of the four-week-old chickens that died showed clear bioluminescence, although 
the signal was not equally distributed over the organs (Figure 5.3). Furthermore, it was 
difficult to homogenize the whole heart or lung of four-week-old chickens making a 
correlation between the luminescence and the concentration of CH2-lux bacteria not possible. 
Therefore, a piece of 2 g of the organs was taken, homogenized (in 2 ml PBS) and transferred 
to a 6-well plate in order to have a more equal distribution of the luminescence, to find a 
better correlation (see Figure 5.4). An evenly distributed signal was found, but chickens that 
acutely died showed a higher signal than euthanized chickens. A correlation could be found 
between bioluminescence and cfu for the heart (R2 = 0.89), liver (R2 = 0.93) and lung (R2 = 
0.89) (Figure 5.5), while no correlation could be found for the spleen (R2 = 0.58). After 
plating ten-fold dilutions of the homogenized organs from CH2-lux infected chickens on LB-
agar many non-luminescent colonies were found, especially in the lungs. The concentration of 
luminescent bacteria (cfu/g) was determined. 
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Figure 5.5. Correlation between ex vivo luminescence of heart, liver, spleen and lung and 
concentration of spiked bacteria in the organs. 10Log values of bacterial numbers relative to ex vivo 10log 
bioluminescent units are graphed. R2 = 0.89 for the heart, R2 = 0.93 for liver and R2 = 0.89 for the lung. 
 
 
 
Figure 5.6. Detection limits of luminescence (10log) after spiking with ten-fold dilutions of CH2-
lux to homogenized organs of four-week-old chickens. Heart (diamonds), liver (squares), spleen (circles) 
and lung (triangles) are shown in relation to bioluminescence units. 
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Detection limits of luminescence in homogenized organs, spiked with ten-fold dilutions of an 
exponentially grown CH2-lux culture in LB medium, are shown in Figure 5.6. The detection 
limit of the luminescence in the heart was between 104 - 105 cfu, while 105 - 106, 105 - 106 and 
> 107cfu were found for the spleen, lung and liver, respectively.  
In order to lower the luminescence detection limit in the spleen and liver, these organs of a 
four-week-old lux-infected chicken were diluted with PBS. Diluting the spleen and liver 
homogenate with a factor 8 resulted in a 4.84 and 8.79 increase of detectable bioluminescence 
activity, respectively (see Table 5.2). 
 
Table 5.2. Effect of dilution of homogenized spleen and liver on detectable luciferase activity  
OrganA  Dilution 
factor 
Bioluminescence 
(p/s/cm2/sr) 
Increase of 
signal 
Spleen  Undiluted 3.12E+07  
 2 2.54E+07 1.63 
 4 2.37E+07 3.04 
 8 1.51E+07 4.84 
Liver  Undiluted 2.89E+07  
 2 2.85E+07 1.97 
 4 2.68E+07 3.71 
 8 2.54E+07 8.79 
            A Homogenized liver and spleen from a CH2-lux infected chicken (106 cfu)  
 
4. Discussion 
The lux operon was successfully chromosomally integrated in APEC isolate CH2, to monitor 
colibacillosis in four-week-old experimentally infected chickens. 
To monitor infection, bacteria can be transformed with various reporters systems. This 
reporter can be for example a modified gfp gene (Pinheiro et al., 2008), but a lux operon has 
more advantages, since it can besides the identification of the infecting strain also be used to 
perform quantification of bacteria. Furthermore, fluorescent markers are known for their high 
background levels and poor penetration of light (excitation and emission) into tissue. The lux 
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operon produces light autonomously and background levels are much lower, offering a system 
with higher specificity and sensitivity (Cronin et al., 2012). 
To follow-up bacteria, they can be transformed with plasmids containing a reporter gene. 
However, these plasmids normally contain a selective marker gene, such as an antibiotic 
resistance gene. Therefore these strains only remain fluorescent/luminescent when grown 
under selective pressure, without losing the plasmid (Pinheiro et al., 2008). Ma et al. (2011) 
detected good stability of an E. coli strain transformed with a GFP plasmid, although stability 
depended on labeled species and strain. Hence, integration of the reporter system into a 
neutral position in the genome is a better option for stable expression of the reporter. During 
this study, the luciferase operon was specifically integrated into the attTn7 site in the genome 
of CH2, not affecting its virulence nor its susceptibility for phage lysis. Furthermore after 
integration into the chromosome, the lux operon is stable without selective pressure (Howe et 
al., 2010).  
As explained in the introduction, Francis et al. (2000) used luminescent Staphylococcus 
aureus bacteria that were injected into the thigh of mice. They were able to find a good 
correlation between the number of fluorescent bacteria re-isolated from the infected tissue and 
the luminescence of the corresponding area. Cronin et al. (2012) was also able to find a good 
correlation between bioluminescence and the concentration of bacteria recovered from 
xenograft tumours in mice. The mice were intravenously injected with lux expressing non-
pathogenic bacteria, since these bacteria form an important vector for cancer treatment, due to 
their preference to grown within tumours. In our study, however, in vivo monitoring of APEC 
infection could not be performed, since we worked with larger animals (four-week-old 
chickens). Therefore, ex vivo scanning of the organs had to be performed on four-week-old 
chickens, an age at which they are more prone to airsacculitis (Dho-Moulin and Fairbrother, 
1999). For the one-day-old chickens however the system on whole bodies was useful. 
Correlations were detected between bioluminescence and concentration of CH2-lux bacteria 
in the homogenized heart, liver and lung of CH2-lux infected chickens, offering a method to 
monitor the effects of different treatments for colibacillosis. Since APEC often starts as a 
localized infection of the air sacs and lungs (Dho-Moulin and Fairbrother, 1999; Gross, 1994), 
this model can be used to determine the effect of treatment with for example bacteriophages 
(as used during this study) or antibiotics. During our study, we tested the capacity of phages 
to lyse CH2-lux ex vivo in the homogenized organs of chickens by measuring the 
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bioluminescence (Figure 5.1). However, organs that were spiked with CH2-lux, but not with 
phages were not included. Therefore, we cannot conclude with certainty that the phages were 
able to lyse CH2-lux, however, there is a strong indication as the bioluminescence clearly 
decreased after the addition of the phages. Phage therapy is an early applied treatment being 
rediscovered, resulting from an increase in antibiotic resistant pathogenic strains. It is, 
however, confronted to many hurdles, among which the discrepancy between an in vitro and 
in vivo environment (Tsonos et al., 2014). The here developed technique allows a rapid and 
better evaluation of the in vivo efficiency of bacteriophages. The labelled strain also has great 
advantages in in vitro cell culture techniques to expand knowledge on the pathogenesis of the 
disease. The strain can for example be added to a monolayer of chicken tracheal epithelial 
cells in order to easily detect under what circumstances APEC can cross the epithelial cells. 
Furthermore, it can be used to infect young chickens in order to follow up adhesion, 
internalization, organ localization, invasion and persistence of the labelled strain via real-time 
imaging, which might provide help in unraveling the pathogenesis. 
A correlation could not be detected between luminescence and concentration of CH2-lux 
bacteria for the spleen, probably due to a higher percentage of blood (haemoglobin) in the 
spleen as compared to the other tested organs. Furthermore, detection limits for luciferase in 
the spleen and liver were high, 105 - 106 and >107 cfu, respectively, and could be decreased 
when homogenized organs were diluted, as previously shown by Colin et al. (2000) for the 
North American firefly luciferase. This can be explained by a decrease of absorbance of the 
luminescent signal by haemoglobin. 
In conclusion, we were successful in developing an APEC strain with an integrated bacterial 
luciferase operon without interfering with its virulence nor its susceptibility to phage lysis. 
Transposition of the lux operon into the chromosome of the challenge strain appeared useful 
for identification of the infecting strain after experimental infection of the chickens. 
Furthermore the system can be used for quantification of the infecting strain in the 
homogenized heart, liver and lung of four-week-old experimentally infected chickens in order 
to monitor colibacillosis and treatment effects.
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A cocktail of in vitro efficient phages is not a guarantee for 
in vivo therapeutic results against avian colibacillosis 
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Abstract 
In this chapter, a cocktail of four different APEC-specific phages was composed and tested to 
cure APEC-infected chickens. Specific phages were selected from a collection of phages 
isolated in Belgium. The selection was based on their obligate lytic infection cycle, a broad 
host range, low cross-resistance and low frequency of development of resistant APEC 
mutants. Genome analysis of the phages indicated they were close relatives of T4 and N4, 
considered to be safe in vivo. Chickens were intratracheally infected with APEC strain CH2 
(serogroup O78), causing a mortality of about 50% during the seven days following the 
infection. The phage cocktail was administered 2 h after the infection, via three different 
ways: intratracheally, intra-esophageally or via the drinking water. Treated groups did not 
show a significant decrease in mortality, lesion scores or weight loss compared to untreated 
groups, although the APEC-specific phages could be re-isolated from the lung and heart of 
chickens that were euthanized. Moreover, the re-isolated bacteria from infected chickens had 
remained sensitive to the phage cocktail. The results in this chapter indicate that the efficiency 
of the phage cocktail used in treating CH2-infected chickens in vivo is negligible, even though 
in vitro, the phages in the cocktail were able to efficiently lyse the APEC strain CH2. Our 
results emphasize that the 'traditional' pathway of isolation, followed by phenotypical and 
genotypical characterization of phages composing the cocktail, does not lead to success in 
phage therapy in all cases.  
The phage isolation, amplification, concentration, purification,  selection and identification of 
phages composing the cocktail as well as the phage characterization, whole genome analysis 
and phage cocktail preparation was conducted by Tsonos (Tsonos, 2014). The stability testing 
of the phage cocktail, in vivo testing of the phage cocktail, bacterial and phage re-isolation 
and resistance testing of re-isolated bacteria against phages was performed by Oosterik and 
Tsonos. 
 
1. Introduction 
Phage therapy is considered to be an effective alternative for antibiotics (Summers, 2001). 
Phages have many advantages over antibiotics, such as being ubiquitous in nature, even 
residing in the gastrointestinal tract of animals and humans and are therefore generally 
considered as safe for application to humans and animals (Johnson, 2008). Obligate lytic 
phages are self-replicating and at the same time self-limiting, meaning that when host cells are 
multiplying, the number of phages will amplify as well. When the host is eliminated, the 
Chapter VI: Bacteriophage cocktail as therapeutic treatment for colibacillosis - 77 
 
phages will also be eliminated (Johnson, 2008). Effective phage therapy reduces bacterial 
numbers, so that the immune response of the host can take over and eliminate the remaining 
infectious bacteria (Levin and Bull, 2004). 
Several reports have shown the successful treatment of APEC in experimentally or naturally 
infected chickens using phage therapy (Huff et al., 2004; Lau et al., 2010; Oliveira et al., 
2010). Oral treatment in a mouse model of intestinal carriage was able to successfully clear E. 
coli O157:H7 from mice (Sheng et al., 2006). 
In this chapter, the efficiency of a phage cocktail against APEC was tested in experimentally 
infected chickens by administration of phages via the trachea, the esophagus or the drinking 
water. 
 
2. Material and methods 
2.1. Bacterial strains and media 
In total 31 APEC strains were used to determine the host range of the phages. The sensitivity 
of six more O78 APEC strains was tested against the suspected O78-specific phages. All these 
strains were isolated from colibacillosis-affected flocks. They belonged to serogroup O78 
(n = 16), O2 (n = 7), O18 (n = 2), O83 (n = 1), O88 (n = 1), O53 (n = 1), O45 (n = 1) and 
O115 (n = 1); seven strains were non-typable (Vandekerchove et al., 2005). The E. coli K-12 
laboratory strains used in this chapter were: MG1655 (Blattner et al., 1997), C600 
(Appleyard, 1954) and K514 (Wood, 1966). Of the tested APEC strains, CH2 (O78) was used 
in the infection model (see Chapter IV and V). Media and growth conditions are as mentioned 
in chapter II and III, unless stated otherwise.  
2.2. Phage isolation and amplification 
Eighty-nine phages were isolated from water samples, collected from rivers and brooks in and 
around Brussels (Belgium) in the vicinity of poultry houses between the year 2000 and 2010. 
Water samples were filtered through a 0.22 µm membrane (Millex® Syringe Filters; Millipore 
Corporation, Billerica, MA, USA) before plating 1 ml on different bacterial APEC strains by 
the double agar overlay method (0.7% agar), as previously described (Adams, 1959). These 
indicator APEC strains belonged generally to the most spread serogroups, namely O1, O2 and 
O78. Some phages could only be isolated after enrichment of the water sample by addition of 
LB (10%) and an overnight culture of the indicator APEC (1%). After overnight incubation, 
the enriched water samples were centrifuged (6120 × g; 10 min). Individual plaques could be 
obtained by applying the double agar overlay method on serial ten-fold sample dilutions. The 
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plaques were plaque-purified twice and amplified. 
2.3. Phage concentration and purification 
Phages were concentrated by polyethylene glycol (PEG) precipitation. A solution consisting 
of 33% PEG (wt/vol) (molecular weight of 8000; Acros Organics, Geel, Belgium) and 1.3 M 
NaCl (Acros Organics) was added in a 1: 5 proportion to the lysates. After overnight 
incubation on ice, the phage lysates were centrifuged (12,500 × g; 20 min). The precipitate 
was resuspended in 10 mM Tris-HCl buffer (pH 8) (Sigma-Aldrich). 
Purification of the phage lysates was performed by continuous CsCl gradient centrifugation. 
Concentrated stocks of individual phages were brought in an aqueous CsCl-solution 
(UltraPure™  Cesium Chloride; Gibco®, Porto, Portugal) with a total density of 1.5. Overnight 
ultracentrifugation (150,000 × g) was performed and the formed opalescent band was 
extracted with a syringe. Each ml extracted volume was dialyzed against 0.5 l medium 
composed of 20 mM Tris-HCl (pH 8), 50 mM NaCl and 10 mM MgCl2, using a membrane 
with Molecular Weight Cut off between 12,000 - 14,000 Daltons (Spectra/Por 4; Spectrum 
Laboratories, Breda, the Netherlands). 
2.4. Selection and identification of phages composing the cocktail 
2.4.1. Host range 
The host range of each phage was determined against 31 serotyped APEC strains (see above). 
Bacterial lawns of each strain were made using the double agar overlay method, on which 
20 µl droplets of the phage stocks (diluted to 106 pfu/ml) were applied. After overnight 
incubation, the degree of lysis of the lawns was determined. 
2.4.2. Virulence of the phages 
The virulent nature of the phages was confirmed by showing that the corresponding phage-
resistant bacterial variants were not lysogenic. Resistant variants were obtained by adding 
100 µl overnight APEC culture and 100 µl of phage lysate (≈ 109 pfu/ml) in the top agar of a 
double agar plate. After overnight incubation, resistant colonies were purified twice on LB 
agar plates. The resistance of the colonies was further confirmed by streaking each colony 
with a loop perpendicularly over a phage line (cross-streaking). Validated colonies were 
cultured in LB. Fifty µl chloroform was added to 1 ml of this overnight culture and kept at     
4ºC for 45 min. After centrifugation at 20,000 × g for 5 min, droplets of 20 µl were brought 
on a double agar plate containing the corresponding sensitive APEC strain. 
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2.4.3. Transmission electron microscopy 
Undialyzed purified phage dilutions were spotted on carbon coated grids (Quantifoil, 
Großlöbichau, Germany) after glow-discharge and negatively stained with 2% uranyl acetate. 
A Philips CM12 microscope was used at 120 kV acceleration voltage. Images were produced 
using a Gatan Orius 1k camera. The dimensions were measured using Gatan Digital 
Micrograph software. 
2.5. Whole genome analysis 
Before phage DNA was extracted from CsCl purified and dialyzed samples by phenol-ether 
extraction, each ml sample was treated with 5 µl DNase I (1 u/µl; Life Technologies Europe 
B.V.) and 8 µl RNase A (10 mg/ml, Life Technologies Europe B.V.) and incubated for 
30 min at 37ºC. An equal volume of phenol (Amresco, Solon, OH, USA) was added to the 
sample and mixed well. This was followed by a phase separation by centrifugation. The upper 
aqueous phase was brought in a new recipient and this phenolization step was repeated two 
more times. To remove the phenol from the sample, ether (saturated with H2O) (Sigma-
Aldrich) was added. After thorough mixing of the samples, the phases were separated by 
centrifugation. The ether extraction was repeated twice. DNA precipitation was performed by 
adding NaCl, to obtain an aqueous phase concentration of 150 mM, together with 2 volumes 
of 100% ethanol. The samples were centrifuged at high speed (18,000 × g) for 20 min, 
whereafter the ethanol was removed. The pellet was washed 2 times with 100% ethanol. After 
removing the ethanol, the pellet was dried and resuspended in 10 mM Tris buffer. 
The genomes of PhAPEC2, PhAPEC5 and PhAPEC7 were sequenced with the Illumina 
sequencing technology at the GIGA facility (Groupe Interdisciplinaire de Génoprotéomique 
Appliquée, University of Liège). The genomes were de novo assembled with a sequence 
coverage of 100 fold. Potentially conflicting regions were detected during gene prediction by 
the occurrence of frame-shifts. In view of the high DNA identity, annotation was performed 
by comparative genome analysis to available type species and using GenemarkTM (Lukashin 
and Borodovsky, 1998). 
2.6. Phage cocktail preparation 
To make high titer stocks, an overnight liquid culture of the bacterial strain was 1: 50 diluted 
into 400 ml fresh LB to obtain a culture with an optical density (OD600) of ≈ 0.1. The culture 
was grown to an OD600 of ≈ 0.2 in an incubator shaker (230 rpm; Innova 4200). Phage was 
added to the culture at a multiplicity of infection (MOI) of ≈ 1 and the culture was incubated 
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further for 2 h (230 rpm), after which 10 ml of chloroform was added and the culture was kept 
at 4ºC for 45 min. The phage lysate was centrifuged (4500 × g; 30 min) and filtered through a 
0.45 µm membrane (Millex® Syringe Filters; Millipore Corporation). Phages were 
concentrated by PEG precipitation and resuspended in LB. The titer of each phage was 
determined the day before the in vivo experiment and diluted so that each dose had a total 
phage concentration of 109 pfu in 500 µl LB, containing equal individual concentrations. For 
the group of chickens that received the cocktail in the drinking water, a dilution in tap water 
was made (109 pfu per 4 ml of water; total volume: 150 ml). 
2.7. Stability of the phage cocktail at 42ºC and in tap water at room temperature 
The stability of the phages in LB medium and PBS was analyzed at 42ºC, the body 
temperature of healthy chickens. Samples were taken daily for 3 days. The titer was 
determined at each time point by plating 20 µl droplets of ten-fold dilution of the samples on 
a bacterial lawn of CH2. 
Phage stability in tap water at RT was tested over 3 h, the time lapse given to the group of 
chickens to empty the given water volume. Phage lysates were diluted 1000 times in tap water 
and kept at RT. The phage titer was determined hourly as described above. 
2.8. In vivo testing of the phage cocktail 
This study was performed in strict accordance with the FELASA guidelines and 
recommendations. The animal experiment was approved by the ethical committee of the KU 
Leuven (Permit Number: P176/2011). The chickens were provided with feed and water ad 
libitum and every effort was made to minimize suffering. Fifty-nine one-day-old chickens 
(Ross; Belgabroed NV) were randomly divided into six groups and housed in a disinfected 
barn. Groups 1 and 2 contained 14 chickens, group 3 contained 13 chickens and the control 
groups 4, 5 and 6 each contained 6 chickens. At four weeks of age, the chickens in the groups 
1 - 5 were weighed and intratracheally infected with 500 µl of the CH2 culture in LB 
(OD600 ≈ 0.6) using a feeding needle (AgnTho's AB, Lidingo, Sweden), as described 
previously (Tuntufye et al., 2012a). Chickens in group 6 were not infected or treated and 
considered as negative control animals, excluding environmental effects. 
Two hours after the infection, chickens in group 1 - 3 were treated with the phage cocktail. 
Group 1 received the cocktail intratracheally, group 2 intra-esophageally and group 
3 via drinking water. The chickens in group 4 received 500 µl of the heat-inactivated 
(autoclaved) phage cocktail intratracheally and were considered as negative control animals. 
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Chickens in group 5 did not receive any treatment and were positive control animals for CH2 
infection. 
Seven dpi all surviving chickens were euthanized by cervical dislocation, weighed and 
necropsy was performed. Macroscopic lesions were scored according to a previously 
described scoring system (Vandemaele et al., 2005). Briefly, macroscopic lesions in the left 
and right thoracic air sac, the abdominal air sacs, the left and right lung, liver and heart were 
each scored from 0 to 2. Intermediate signs for APEC lesions were scored between 0.5 and 
1.5. Chickens that died or were euthanized because of serious clinical APEC symptoms were 
given the full score (14), after confirming severe APEC lesions on necropsy. Lungs and heart 
were aseptically removed from chickens that were euthanized for re-isolation of phages and 
bacteria (as described below). Lungs and heart were chosen as local and systemic organ, 
respectively. Organs were not taken for re-isolation of phages and bacteria from chickens that 
were found dead after the infection, since uninhibited growth has taken place. 
To have an indication of the bacterial load and phage presence in chickens without severe 
clinical signs, two randomly selected chickens from group 1 and 2, and one chicken from 
group 3 were sacrificed 24 h after treatment. Lesions were scored and the lung and heart were 
removed aseptically. The 24 h time point was chosen, since a preliminary study showed no 
administered phages could be re-isolated at that time point from the organs of chickens in the 
absence of a CH2 infection (data not shown). 
2.9. Statistics 
All results were analyzed with Analyze-it (Analyze-it Software Ltd.) in Microsoft Excel 
(2010). Medians, first and third quartiles (Q1 - Q3) were determined for the total lesion score, 
and lesion score per organ for every group of chickens. The Kruskal-Wallis test was used for 
determining the significance of the differences in lesion scores between multiple groups, and 
the Wilcoxon Rank Sum Test for assessing differences between each pair of groups. These 
tests were used since a low number of chickens was present per group and data were non-
parametric. Live weight gain was determined for chickens that were still alive 7 dpi. The 
weight gain of the chickens that were still alive 7 dpi was tested for a normal distribution. 
Welch's ANOVA test was performed, since weight gain was not normally distributed, to 
analyze the significance of differences in weight gain between multiple groups. Weight gain 
between each pair of groups was tested with the Welch's t-test. P ≤ 0.05 was considered 
significant and 0.05 < P < 0.10 a trend toward significance. 
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2.10. Phage re-isolation 
Heart and lungs (2 g) were homogenized in 2 ml PBS using an Ultra-Turrax T25 homogenizer 
with dispersing element (IKA®-Werke GmbH & Co. KG, Staufen, Germany). A 2 ml tube 
was filled with homogenized organ. To enable the detection of phages that are present in low 
numbers, the remaining material was enriched by adding 4 ml of LB together with 4 µl of 
CH2 overnight culture. The suspension was incubated overnight (230 rpm). The non-enriched 
homogenized organs and 1 ml of the enriched organ samples were centrifuged (6100 × g; 
10 min), the supernatant was collected and 50 µl chloroform was added. Subsequently, 
respectively 50 µl droplets and 20 µl of ten-fold serial dilutions were plated on a bacterial 
lawn of CH2 and incubated overnight. An optimized multiplex PCR reaction (four specific 
primer pairs) was performed on single plaques, to allow the identification of phages which 
could still infect the CH2 strain in vitro. The primers were designed on unique loci within the 
genomes (see Table 6.1). The master mix contained 1.0 µl of each primer (20 µM), 2.0 µl of 
DreamTaq buffer (10x), 0.2 µl DreamTaq ™  DNA polymerase (5 u/µl, Life Technologies 
Europe B.V.) 0.5 µl dNTPs (10 mM) and 9.3 µl sterile Milli-Q water. The following PCR 
conditions were used: 95ºC for 15 min (initial denaturation), 35 cycles [of 94ºC for 30 s 
(denaturation), 58ºC for 30 s (annealing), 72ºC for 1 min (elongation)], and 72ºC for 5 min
(final elongation). The products were visualized on a 2% agarose gel. 
 
       Table 6.1. Oligonucleotides used in this chapter 
Phage Sequence (5' to 3') Amplified fragment 
size (bp) 
Reference 
PhAPEC2 GGTAGTGCCTTCACCTTA 
663 
This study 
 CGTGCAATGCAACCTTAC This study 
PhAPEC5 CCAGAAAGGGGATTGATG 
347 
This study 
 GATACATGCTTGACCACC This study 
PhAPEC7 GTTCAACATGTCTCCGTC 
788 
This study 
 GCCACCATTGGTTTGAAC This study 
PhAPEC9 GTAGGACTGGAAGCCAAG 
445 
This study 
 GGTTCGGTGTCTTCTCG This study 
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2.11. Bacterial re-isolation 
Ten-fold serial dilutions of homogenized lungs and heart were plated on LB agar and lungs 
additionally on MacConkey agar (Oxoid CM0115; Oxoid N.V.). After 24 h of incubation, the 
number of cfu was determined. 
2.12. Resistance of re-isolated bacteria against phages 
Ten colonies were re-isolated from the heart and lungs (lung: MacConkey agar, heart: LB 
agar) to test resistance against the phage cocktail and individual phages. By cross-streaking, 
resistance of the re-isolated colony can be detected when uninhibited bacterial growth beyond 
the phage line is seen. To confirm the cross-streaking, spots (20 µl) of serial ten-fold dilutions 
of the phage cocktail and the individual phages were put on bacterial lawns of three of those 
re-isolated colonies per organ. As controls APEC CH2 was used (lysed by the four phages) 
and APEC strains APEC21 and APEC125 (lysed by none of the phages). 
 
3. Results 
3.1. Selected phages PhAPEC2, PhAPEC5, PhAPEC7 and PhAPEC9 are lytic phages   
suitable for a therapeutic cocktail in vitro 
The host range is essential information for further applications. Our selection was based on a 
broad lytic spectrum combined with a high degree of lysis against the 31 tested APEC strains. 
The eight most outstanding phages were selected from the phage library. Four of these phages 
were able to lyse model strain CH2 and were selected to compose the cocktail. These phages 
were: PhAPEC2, PhAPEC5, PhAPEC7 and PhAPEC9. They were able to lyse respectively 19 
out of 31, 6 out of 31, 9 out of 31 and 10 out of 31 tested APEC strains. PhAPEC2 infected 
APEC strains of serogroups O45 (1/1), O78 (9/10), O2 (5/7), O18 (2/2), O83 (1/1), one non-
typable strain (1/7) and also E. coli K-12 strains. PhAPEC5, PhAPEC7 and PhAPEC9 are 
likely to be O78-specific phages. PhAPEC9 grew exclusively on all of 10 tested O78 strains. 
The lytic activity of PhAPEC5 and PhAPEC7 was tested on the 16 available O78 APEC 
strains, because they were able to grow exclusively on O78 strains, but did not lyse all O78 
strains. PhAPEC5 could lyse 11 out of 16 O78 APEC strains and PhAPEC7, 13 out of 16. 
With O78 being one of the most common APEC serogroups, putative O78-specificity is a 
valuable characteristic (Schouler et al., 2012). 
The strictly lytic character of the phages was a prerequisite for our study. All re-isolated 
phages turned out to be virulent. No phages were present by spontaneous induction in the 
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overnight cultures of the phage-resistant bacterial variants, implying that they did not become 
immune due to lysogeny. 
Analysis of the transmission electron microscopy images suggested PhAPEC5, PhAPEC7 and 
PhAPEC9 to be Podoviridae related to coliphage N4, whereas PhAPEC2 is a member of 
the Myoviridae with a T4-type morphology (Figure 6.1). The T4-like phages have already 
been described as ‘safe’ in numerous phage therapy applications (Brüssow, 2005). The N4-
like phages are also favored for this purpose and are also part of commercial mixtures (Krylov 
et al., 2013). The sizes of the phage heads were in agreement with the sizes of the 
corresponding sequenced genomes; the N4-like phages had a genome size approximating 
71 kb with head dimensions of 65 nm and 70 nm. The T4-type phage PhAPEC2 had a head 
dimension of 83 nm and a genome size of 167 kb. 
 
                 
Figure 6.1. Transmission electron microscopy pictures of the four phages composing the 
cocktail. A) T4-like phage PhAPEC2 (head: 83 nm and tail: 107 nm); the N4-like phages: B) PhAPEC9 (head: 
64 nm), C) PhAPEC5 (head: 65 nm) and D) PhAPEC7 (head: 70 nm). Transmission electron microscopy 
pictures made by prof. J. Klumpp (Institute of Food, Nutrition and Health, ETH Zurich, Switzerland). 
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Full genome sequencing of the selected phages confirmed the relationship to phages N4 and 
T4, respectively. The genomes of PhAPEC5 and PhAPEC7 both showed a DNA sequence 
coverage of 63% similar (E = 0) to Escherichia phage N4 (NC_008720.1). PhAPEC5 shows 
amino acid similarity with N4 for 54 out of its 83 proteins; PhAPEC7 for 55 out of its 85 
proteins. PhAPEC2 had a DNA sequence coverage of 72% similar to Enterobacteria phage T4 
(NC_000866.4) and had 202 of its 254 proteins similar to T4 proteins, based on blast analysis. 
Gene annotations did not identify potential known toxins or toxin-related pFAM domains. In 
addition, no genomic markers indicating a temperate lifestyle were found. The genome 
sequences of phages PhAPEC2, PhAPEC5 and PhAPEC7 have been submitted to GenBank 
(KF562341, KF192075 and KF562340). 
3.2. The selected cocktail displayed acceptable stability parameters 
The titer decrease of the phages at 42ºC over 3 days was variable and depended on the 
medium and the phage. In LB medium, PhAPEC9 showed a negligible titer drop, whereas 
PhAPEC5 titers decreased with 3.7 log units. PhAPEC2 and PhAPEC7 had an intermediary 
titer reduction. In PBS medium the titer drop varied between a reduction of 1.4 log units for 
PhAPEC7 and 2.3 log units for PhAPEC2. However, all phages showed good stability in tap 
water and no titer drop exceeding 0.5 log were detected over a 3 h time period (the period 
necessary for drinking water administration). 
3.3. Phage treatment did not reduce mortality and lesions scores 
Mortality rates, medians and Q1 - Q3 for the lesion scores are presented in Table 6.2. No 
significant differences were found for the mortality between the infected chickens of groups 
1, 2, 3, 4 and 5. Significant differences between multiple groups were found for the total 
lesion score and lesion score per organ (P < 0.01). The Wilcoxon Rank Sum Test showed 
significant differences between infected chickens from group 1 - 5 in comparison to the non-
infected group 6, for the total lesion score and the lesion score per organ (P < 0.05). Between 
groups 1 - 5 no significant difference were found for the total lesion score or the lesion score 
per organ. A trend toward significance (P ≈  0.06) was found for the lesion score of the liver 
and abdominal air sac of chickens in group 4 in comparison to non-infected group 6. 
 
 
 
  
 
         Table 6.2. Mortalities and lesion scores of chickens infected with CH2 and treated with a phage cocktail 
     Median of lesion scorese (first quartile – third quartile) 
Group Infectiona Treatmentb Totalc Deathsd Liver PRD TAS-L TAS-R LU-L LU-R AAS TOT 
1C/B CH2 109 IT 12 6 2A 2A 2A 2A 2A 2A 2A 14A 
     (1.75 – 2) (2 – 2) (2 – 2) (2 – 2) (2 – 2) (2 – 2) (1.5 – 2) (13.25 – 14) 
2C/B CH2 109 ES 12 6 2A 2A 2A 2A 2A 2A 2A 14A 
     (2 – 2) (2 – 2) (2 – 2) (2 – 2) (2 – 2) (2 – 2) (2 – 2) (14 – 14) 
3C/B CH2 109 DR 12 5 2A 2A 2A 2A 2A 2A 2A 14A 
     (2 – 2) (2 – 2) (2 – 2) (2 – 2) (2 – 2) (2 – 2) (1.75 – 2) (13.25 – 14) 
4C/B CH2 109 inactive 6 4 2AB 2A 2A 2A 2A 2A 2AB 14A 
     (0 – 2) (1 – 2) (2 – 2) (2 – 2) (2 – 2) (1 – 2) (0 – 2) (14 – 14) 
5C/- CH2 - 6 3 2A 2A 2A 2A 2A 2A 2A 14A 
     (1.5 – 2) (2 – 2) (2 – 2) (2 – 2) (2 – 2) (2 – 2) (1 – 2) (14 – 14) 
6LB/- - - 6 0 0B 0B 0B 0B 0B 0B 0B 0B 
     (0 – 0) (0 – 0) (0 – 0) (0 – 0) (0 – 0) (0 – 0) (0 – 0) (0 – 0) 
              aIntratracheal infection with 500 µl 108 cfu CH2 at 28 days of age. 
              bChickens were, 2 hours after the infection, treated via the trachea (IT), oesophagus (ES) or via the drinking water (DR) with the phage cocktail with a concentration of       
          109 pfu 
         cTotal number of chickens per group.  
              dTotal number of chickens that died or were euthanized in 7 days following the infection. These chickens showed clear macroscopic lesions of an APEC infection and  
          were assigned a total lesion score of 14.  
              ePRD = pericardium; TAS-L = left thoracic air sac; TAS-R = right thoracic air sac; LU-L = left lung; LU-R = right lung; AAS = abdominal air sacs; TOT = total lesion  
          score.  
          Different capital letters show significant differences within the column (P ≤ 0.05).         
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Table 6.3. Time of death, concentration of re-isolated bacteria and presence of phage in organs 
from chickens 
Chicken Organ Time of 
death 
(dpi)a 
Group Lesion 
score 
Bacterial concentration        
(cfu/g) 
Phage presence 
LB MacConkey Without 
enrichmente 
With 
enrichmente 
1 Lung 1b 1 2 3.8E+08 4.8E+07 + + 
 Heart   0 1.0E+08 N.D. + + 
2 Lung 1b 1 2 6.8E+08 9.0E+07 + + 
 Heart   2 4.0E+02 N.D. - - 
3 Lung 1b 2 1.5 6.3E+07 1.0E+08 - - 
 Heart   0 1.6E+07 N.D. - - 
4 Lung 1b 2 2 1.5E+09 8.6E+07 - - 
 Heart   2 2.6E+08 N.D. - + 
5 Lung 1b 3 2 1.7E+06 1.8E+08 - - 
 Heart   0 2.6E+03 N.D. - - 
6 Lung 2c 1 2 2.4E+07 1.4E+07 + + 
 Heart   2 7.8E+05 N.D. - - 
7 Lung 2c 3 2 4.2E+08 7.5E+07 - - 
 Heart   2 1.2E+08 N.D. - - 
8 Lung 3c 3 2 1.5E+05 2.4E+05 - - 
 Heart   2 3.8E+07 N.D. - + 
9 Lung 4c 2 2 8.5E+06 5.5E+06 - - 
 Heart   2 9.8E+05 N.D. - + 
10 Lung 5c 4 2 2.0E+07 6.0E+06 N.D. - 
 Heart   2 8.0E+07 N.D. N.D. - 
11 Lung 5c 5 2 4.0E+07 1.8E+07 N.D. - 
 Heart   2 5.2E+08 N.D. N.D. - 
12 Lung 6c 1 2 6.8E+05 5.7E+04 - - 
 Heart   2 7.4E+05 N.D. - - 
13 Lung 7d 1 2 2.2E+06 6.5E+06 N.D. N.D. 
 Heart   2 7.6E+07 N.D. N.D. N.D. 
14 Lung 7d 2 2 7.3E+03 5.2E+03 N.D. N.D. 
 Heart   2 1.2E+06 N.D. N.D. N.D. 
15 Lung 7d 3 2 5.0E+03 2.1E+03 N.D. N.D. 
 Heart   2 1.5E+06 N.D. N.D. N.D. 
a Days died/euthanized after infection  
b Chickens randomly chosen and sacrificed 1 day after infection and treatment 
c Chickens euthanized after infection 
d Chickens still alive 7 days after infection 
e  - = phage not present; + = phage present 
N.D. = not determined 
 
 
 
 
 
88 - Chapter VI: Bacteriophage cocktail as therapeutic treatment for colibacillosis 
 
3.4. Phage treatment did not procure a significant weight gain 
Weight gain in chickens that were euthanized 7 dpi was determined (data not shown). 
Chickens in all groups, except for groups 3 and 6, showed an average weight loss 7 dpi. No 
significant differences were found in weight gain between chickens in groups 1, 2, 3, 4 and 5 
(P ≈  0.83), indicating that treatment with the phage cocktail did not significantly influence the 
weight gain of the chickens. The weight gain in chickens from group 6 was significantly 
different from the other groups (P < 0.01), showing that the infection had a significant effect 
on the weight gain of the chickens. 
3.5. Viable phages could be re-isolated from euthanized and sacrificed chicken 
Phages could be re-isolated from organs of chickens that were sacrificed or euthanized; both 
with and without enrichment (see Table 6.3). However, to re-isolate phages after 48 h the 
organs had to be enriched, demonstrating the low concentration of phages beyond this time 
point. Phages have been found up to four days after treatment. The presence of phage in dying 
chickens indicates their inability to rescue the chickens from a developing infection. 
Phages could be re-isolated from the heart (but not the lungs) in chickens treated via the 
esophagus or via the drinking water, suggesting that the phages could translocate from the 
gastrointestinal tract to the cardiovascular system. Phage identification by multiplex PCR 
(Table 6.4) recognized PhAPEC2 (in group 2 after 4 days) and PhAPEC7 (group 2 after 24 h, 
group 3 after 3 days). Phages could be re-isolated from the heart as well as from the lung from 
chickens that received phage intratracheally. After 24 h, all four phages could be re-isolated 
from the lung tissue and only PhAPEC5 could not be re-isolated at the 48 h time point. 
PhAPEC 2 (after enrichment), PhAPEC7 and PhAPEC9 could be detected in the heart. These 
data give a general indication of the translocation capacity of each phage in a cocktail context. 
Despite the presence of phages in three of the five randomly chosen chickens, which were 
sacrificed after 24 h, high bacterial concentrations and lesion scores were observed. 
In a previous unpublished study, the presence of phages was followed over time in the organs 
in absence of CH2 infection. No phages could be detected 24 h post administration. Since this 
is in contrast with the results in this study, where phages could still be re-isolated after four 
days, we can hypothesize that during this study multiplication of the phages in vivo has likely 
taken place. 
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Table 6.4. Identification of re-isolated phages from organs by multiplex PCR 
Chicken Organ Time of 
death (dpi)a 
Group Presence of phage 
    Without enrichment With enrichment 
1 Lung 1b 1 PhAPEC2, PhAPEC5, 
PhAPEC7, PhAPEC9 
PhAPEC2, PhAPEC7 
 Heart 1b 1 PhAPEC7, PhAPEC9 PhAPEC7, PhAPEC9 
2 Lung 1b 1 PhAPEC5, PhAPEC7, 
PhAPEC9 
PhAPEC2, PhAPEC7 
4 Heart 1b 2 X PhAPEC7 
6 Lung 2c 1 PhAPEC7, PhAPEC9 PhAPEC2, PhAPEC7 
8 Heart 3c 3 X PhAPEC7 
9 Heart 4c 2 X PhAPEC2 
 a Days euthanized after infection 
b Chickens randomly chosen and sacrificed 1 day after infection and treatment 
c Chickens euthanized after infection 
X = not present  
 
3.6. Bacterial quantification and sensitivity to the phage cocktail 
The concentration of bacteria that were re-isolated from the lungs and heart of euthanized or 
sacrificed (24 hpi) chickens are provided in Table 6.3. The number of re-isolated bacteria in 
chickens sacrificed 24 hpi varied between 106 – 109 cfu/g in the lung and between 102 –
108 cfu/g in the heart. In the euthanized chickens, concentrations varied between 103 –
108 cfu/g in the lungs and between 105– 108 cfu/g in the heart. 
We determined the level of resistance to phage infection which had developed during the 
treatment period. All colonies, except two (see Figure 6.2), showed sensitivity to the phage 
cocktail and the individual phages in cross-streaking screens. The sensitivity of the colonies 
was confirmed with the drop test on the bacterial lawn of three re-isolated colonies per organ. 
These re-isolated colonies had the same sensitivity as the wild type CH2 strain for the phages; 
individual plaques could be observed at a 10-3 dilution of the cocktail. The sensitivity for the 
O78-specific phages PhAPEC5, PhAPEC7 and PhAPEC9 confirms that E. coli CH2 was re-
isolated from these chickens. 
Two colonies re-isolated from the heart of chicken 22 (treated via the esophagus and 
euthanized 7 dpi) had a decreased sensitivity for the cocktail, as observed by cross-streaking 
and the soft agar overlay technique. With cross-streaking, an uninhibited bacterial line beyond 
the phage cocktail line was observed (Figure 6.2), and with the soft agar overlay technique 
individual plaques were seen at a lower dilution compared to CH2 (data not shown). The 
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resistance against each individual phage of the cocktail was subsequently analyzed. An 
increased resistance was found against all four phages for one colony and against two phages 
(PhAPEC9 and PhAPEC7) for the other colony. 
 
Figure 6.2. Cross-streaking of the re-isolated colonies over a phage cocktail line. A) and B) Re-
isolated colonies from chicken 22, colony 1 and 7 showing resistance against the phage cocktail, C) Positive 
control strain APEC CH2 showing sensitivity to the phage cocktail and negative control strains APEC125 and 
APEC21 showing resistance against the phage cocktail. 
 
4. Discussion 
Successful application of phages for the treatment of natural or experimental APEC infections 
in chickens has been reported (Huff et al., 2004; Lau et al., 2010; Oliveira et al., 2010). 
Success rates were different and dependent on many factors, such as type of administered 
phages and route of administration of the phages (Huff et al., 2003b). Timing and 
concentration of administered phages is also known to have an important effect on the success 
rate of phage therapy (Ryan et al., 2011), with successful treatment even seen after 
administration of phages within one or two days after the bacterial infection (Watanabe et al., 
2007). An early administration after infection can lead to clearing of phages before they can 
actively replicate in vivo, caused by a too low bacterial concentration (Payne et al., 2000). 
However, in the current study, low phage titers could be recovered from the lungs and heart of 
chickens at different time points after administration, even 3 and 4 dpi. These phages were 
identified as PhAPEC7 (3 dpi) and phAPEC2 (4 dpi), respectively. Although these phages 
most likely were able to multiply in vivo, and despite the fact that phages (low titer) could be 
re-isolated from the heart and lungs, they were not able to clear the infection. 
Bacterial numbers in the organs of infected/non-treated and infected/treated chickens seemed 
not to be significantly different, leading to the conclusion that phages were not able to 
significantly lower the number of bacteria in the organs. The reason for this cannot be found 
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in the in vitro efficacy of the phages, since the phages in the cocktail were able to efficiently 
lyse CH2, and their stability in LB and PBS at 42ºC was demonstrated. Only PhAPEC5 
showed reduced stability at 42ºC and could indeed not be re-isolated from euthanized 
chickens 2, 3 or 4 dpi, unlike the three other phages in the cocktail. 
One possibility is the intracellular multiplication of CH2 (for example in macrophages or 
heterophils), preventing phages from reaching their receptor on the bacterial host and 
avoiding infection and lysis. Strain APEC O1:K1:H7 has been shown to survive in 
macrophages (Mellata et al., 2003), probably by protecting itself against the environmental 
stresses (such as acidity) by production of colanic acid (Li et al., 2005; Tuntufye et al., 
2012a). However, APEC CH2 belongs to serogroup O78 which was shown to be poorly 
associated with phagocytes (Mellata et al., 2003). It is thus less likely that CH2 will multiply 
intracellularly.  
Another possibility lies in the transcriptional response to environmental stresses (Mekalanos, 
1992). It was shown by recombination-based in vivo expression technology that genes 
involved in capsule formation and transport are expressed in vivo in chickens (Tuntufye et al., 
2012a). Attenuated mutants were found by signature-tagged transposon mutagenesis, which 
contained mutations in genes responsible for capsule formation (kpsM and kpsS), showing that 
it is likely that capsule formation is necessary for the virulence and survival of APEC in 
vivo (Li et al., 2005). It was shown that a spontaneous K1 mutant of APEC strain MT78 was 
not able to persist in body fluids and colonize systemic organs, furthermore it showed 
sensitivity to serum and phagocytosis, whereas the wild type strain was resistant (Mellata et 
al., 2003). Phage T7, with its receptor on LPS, was physically blocked to lyse E. coli strain 
EV36 after the expression of its K1 capsule in vitro (Scholl et al., 2005). To test if the phages 
in the cocktail were able to lyse the bacteria after capsule formation, CH2 was grown to 
exponential phase in milk broth (capsule formation was observed). The phage cocktail was 
added to one of the cultures when it reached exponential phase (OD600 ≈  0.6) and OD was 
followed over time. A significantly lower OD600 over time was found in the culture with the 
phage cocktail added to it in comparison to the culture without phages (data not shown), 
which implies that the phages were able to lyse the bacteria even though they expressed the 
capsule. 
Bacterial resistance to phages by mutation or loss of phage receptors has been shown to be a 
major cause of unsuccessful phage therapy (Levin and Bull, 2004; Ryan et al., 2011; Skurnik  
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and Strauch, 2006). This is not the case here, since a phage cocktail with phages having 
different receptors and not showing cross-resistance was used in order to reduce resistance 
development (Levin and Bull, 2004). In addition, resistance of the recovered bacteria to the 
phage cocktail was verified and shown to be very limited (only two isolates with a lower 
susceptibility to the phage cocktail could be found). As such, an unsuccessful treatment due to 
resistance development is unlikely. 
Little is known about the behaviour of phages in vivo (Skurnik and Strauch, 2006). It is 
possible that the applied phages were not active enough in vivo, due to encountering a 
suboptimal environment. Moreover, clearance of the phages by the general innate immune 
system cannot be excluded because of the presence of systemic inflammation. The decrease in 
number of the phages would make it difficult to spread through the body in high enough 
amounts to fight a systemic infection. In future, it is important to achieve a better 
understanding of the behaviour of phages in vivo to be able to select phages and conditions for 
their application that show the best results in human and animal therapy. 
Colibacillosis can be considered as a severe infection, which starts as a respiratory infection 
that rapidly becomes systemic. Huff et al. (2013) did not obtain a reduction in mortalities in 
APEC infected chickens when treated via fine or coarse spray. However, a decrease could be 
obtained after intratracheal treatment. This observation was explained by the fact that only 
intratracheal administration could bring high enough phage titers at the infection site (Huff et 
al., 2013). The experimental design of Huff et al. (2013) varies in many points with ours, with 
the most striking being that infection was performed immediately after treatment. A 
sufficiently high phage administration in the lungs and air sacs could prevent an important 
systemic spread, which in comparison with our study already occurred because treatment was 
administered 2 h after infection. This hypothesis was confirmed, since bacteria were observed 
in the blood of four-week-old chickens two h after intratracheal infection with CH2 (H.N. 
Tuntufye, personal communication). Such systemic infections may not be treatable using 
phage in this manner, and phage therapy efforts should possibly focus on prevention rather 
than treatment. Intramuscular treatment showed significant decreased mortality even when 
phages were administered 48 h after infection, but is not practical in large productions (Huff 
et al., 2003b). 
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This study and others show that phage therapy is not always successful. Sheep and cattle 
infected orally with E. coli O157:H7 and treated repeatedly orally with large doses of phage 
KH1 did not show a lower intestinal carriage of E. coli O157:H7 compared to control groups 
that were not treated by phages (Sheng et al., 2006). Despite an overwhelming optimism in 
literature about the efficacy of phage therapy, the specific fields of application should be more 
clearly investigated and defined. 
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1. Zoonotic potential of APEC and antibiotic resistance and its 
consequences 
It has been shown that some APEC isolates are genetically indistinguible from UPEC and 
NMEC isolates, sharing many virulence genes, O-serogroup and a phylogenetic subcluster 
(Ewers et al., 2007; Johnson et al., 2008; Moulin-Schouleur et al., 2007). Human strains of 
this subcluster were highly virulent for chicks (Moulin-Schouleur et al., 2007). So even 
though most APEC, UPEC, and NMEC strains are genetically distinct from one another, a 
subcluster is not. This cluster shows the zoonotic potential of APEC. Phages might be used to 
kill APEC bacteria on poultry meat. There have not been investigations on the use of phages 
for APEC on meat yet, since this is not the most important pathogen on food. Considering  the 
potential zoonotic risks of APEC and also its multidrug resistance, especially in strains from 
broilers (Blanco et al., 1997; Peighambari et al., 1995; Zahraei Salehi and Farashi Bonab, 
2006), the transfer of antibiotic resistance genes to human bacteria, as shown in an in vitro 
model (Smet et al., 2011), should be inhibited. Since 1999 several stricter regulations 
concerning antimicrobial use have been applied in the European Union, with the ban on 
antimicrobial growth promoters in 2006 probably as the most important one. The consequence 
of the ban was an initial increase in use of antimicrobials for therapeutic use, as shown in 
Denmark (DANMAP, 2008), the Netherlands (MARAN, 2007) and Sweden (SVARM, 2007). 
From 2007 - 2012 there was a decline of 56% in therapeutic use of antibiotics (kg active 
substance) in the Netherlands (SDa, 2013), however its effect on the occurrence of resistance 
in indicator E. coli strains is not yet noticeable (MARAN, 2012). Since 2007, an antimicrobial 
consumption monitoring system exists in Belgium (www.belvetsac.ugent.be). The monitoring 
program in Belgium shows a decline of antimicrobial use in the animal product sector by 
20.3% from 2007 to 2012, although Belgium remains one of the highest antimicrobial users in 
the European Union (BelVetSac, 2012). In Belgium the most used compounds in the broiler 
industry are amoxicillin, tylosin and trimethoprim-sulfonamide, belonging to risk class I 
(critically important) for human medicine with the exception of  trimethoprim-sulfonamides 
(class II; highly important) (Persoons et al., 2012). Among AFEC isolates from healthy 
broilers (sampled in 2011) high levels of resistance (more than 50%) were found for 
ampicillin, ciprofloxacin, nalidixic acid, streptomycin, sulfonamides and tetracyclines (EFSA, 
2013), which makes it a challenge to treat the disease in broilers. Next to this, APEC is hard 
to treat, especially in broilers with their poor immunocompetence due to selection for 
increased growth, which is negatively correlated with maturation of the immune system and 
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the level of the immune response (Maatman et al., 1993; Siegel et al., 1982). Few data are 
available for laying hens. In our study, we found high resistance to ampicillin, nalidixic acid, 
sulfonamides and tetracycline and observed that 37% of the strains from the year 2000 - 2005 
were multi-resistant (Chapter II). However, more recent data with respect to antibiotic 
resistance in laying hens are needed, even though laying hens are rarely given antibiotics. In 
laying hens no mass outbreaks of colibacillosis occur, only a limited number of laying hens 
gets infected that are difficult to treat, furthermore there is the risk of antibiotic residues 
ending up in the eggs. These residues can pose risks to human health, due to allergic reactions 
in hypersensitive persons. They can also cause direct toxic effects or code for increased 
bacterial resistance to antibiotics, if humans are exposed for a relatively long period (Bogialli 
and Di Corcia, 2009; Dowling, 2013; Goetting et al., 2011). Therefore maximum residue 
limits have been set by the European Union (European Parliament, 2009). So APEC infected 
laying hens often do not get treated, but are culled. However, during rearing layers do receive 
antibiotics, and antibiotic resistant bacteria can persist for a long time in the intestinal tract of 
chickens without selective pressure of antibiotics (Chaslus-Dancla et al., 1987). During this 
study a two-way strategy was tested to reduce the need for antibiotics and likewise in an 
indirect manner contribute to diminish the antimicrobial resistance burden in poultry. On the 
one hand trying to prevent environmental colonization (or flock to flock transmission) of 
APEC and lowering infection pressure in the presence of chickens by the use of disinfectants 
and on the other hand focusing on treating APEC infected chickens by the use of a phage 
cocktail.  
 
2. Use of disinfectants to prevent colibacillosis 
2.1. Current techniques for testing disinfectant resistance 
In our studies we evaluated a collection of APEC strains (n = 97) for resistance against the 
five most included active ingredients in commercial disinfectants, routinely used in the 
poultry industry (Chapter II). We based our data on information provided by Animal Health 
Care Flanders and the Federal Agency for Medicines and Health Products, since no exact data 
on the quantities of the different products can be obtained. We did not find any resistance, 
however through the presence of integrons we know that resistance genes are present. This 
indicates that the current techniques for evaluating phenotypic resistance against disinfectants 
should be further optimized. Furthermore, no breakpoints concentration cut-offs exist for 
distinguishing between susceptible and resistant strains, as there are for antibiotic 
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susceptibility testing. Detection of resistance solely depends on the distribution of the strains 
over the MICs (microbiological breakpoints). A more sensitive standardized method will be 
needed (Maillard et al., 2013; Russell, 1999) to be able to compare results at an international 
level. Therefore, first of all a clear definition between reduced susceptible (increased MIC) 
and resistant (not active at in-use concentration) is necessary (Maillard et al., 2013; Russell, 
1999). Using MBCs instead of MICs might also already be a step in the this good direction, 
since this reflects the concentration at which the biocide kills, which is of more importance in 
the case of disinfectants than the MIC (Russell, 1999). Furthermore the use of doubling 
dilutions in the determination of phenotypical resistance should be reconsidered, since 
doubling dilutions might not be sensitive enough to detect resistance. PCRs to detect the 
presence of qac resistance genes have been developed. However, other resistances (such as 
genes coding for other multidrug efflux pumps or yet unknown resistance genes) may not be 
detected like this. These unknown resistance genes may be identified by using mutagenesis 
techniques, inactivating the gene in question.  
 
2.2. Biofilm formation and its effects on disinfectant efficacy 
Biofilms can impair substantially the efficacy of disinfectants and biofilms cells are in general 
more resistant (tolerant) to biocides than planktonic cells. During our study we found most of 
the APEC strains to be moderate biofilm producers on PS and strong biofilm producers on PP 
and PVC, under standardized conditions which can be encountered in the barns, especially in 
the water systems (Chapter III). Strains of serogroup O1 and O2 belonged significantly more 
often to the strong biofilm producers than to the non-, weak or moderate biofilm producers, 
while strains of serogroup O78 were mainly non- or weak biofilm formers on PP and PVC. 
On SSCs, strains of serogroup O78 were mainly moderate to strong biofilm producers, while 
strains of serogroups O1 and O2 were mostly non- to weak biofilm producers. The in-use 
concentrations for QAC are higher than the obtained concentrations needed to kill the sessile 
cells during our study, while the obtained concentration for H2O2 is higher than the lowest in-
use concentration and lower than the highest in-use concentration. Reactivity with organic 
material is especially known for highly reactive compounds (like H2O2) (Russell 1999). 
However, a concentration of 2-3% H2O2 was shown to possess good antimicrobial activity in 
the presence of organic matter (Moustafa Gehan et al., 2009; Ruano et al., 2001), while tested 
in-use QAC concentrations were more affected (Moustafa Gehan et al., 2009). Disinfectants 
are nevertheless often a combination of various active ingredients, together they have a higher 
efficacy. In this study we worked with relatively young biofilms, while in barns probably 
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much more elaborated biofilms may be formed. Little research exists on biofilms in poultry 
houses under natural conditions, so the effect of biofilm formation on disinfectant efficacy 
should be assessed in poultry houses. Thereby also concrete should be tested under natural
conditions, which in a broiler house is the most used material.  
2.3. Lowering infection pressure of APEC by use of disinfectants 
Since APEC strains are present, also in healthy animals, lowering infection pressure in the 
presence of chickens in barns can be an important strategy to help reduce APEC outbreaks. 
High concentrations of faeces contaminated dust are usually present in the barn. As APEC 
infection is mainly believed to be caused by inhalation of these dust particles (aerosols) (Dho-
Moulin and Fairbrother, 1999; Dziva and Stevens, 2008), lowering the level of these E. coli 
aerosols might possibly result in a lower incidence of APEC outbreaks. This applies 
especially to broilers between 4 weeks up to slaughter, since broilers of that age experience 
high levels of stress due to their fast growth, which renders the chickens more prone to 
infection. High concentrations of ammonia, which are present in the poultry house when 
chickens reach this age, furthermore predispose chickens to APEC. As such, lowering the 
infection pressure in chickens needs to be further explored, since nebulization of low 
concentrations (higher than 1%) of H2O2 has been shown to render chickens more susceptible 
to APEC infection, rather than lowering the infection pressure (Chapter IV). This is probably 
due to the caustic effect of hydrogen peroxide radicals on the epithelial cells in the pharynx 
and trachea, most likely deciliating epithelial cells. This, however, needs to be confirmed by 
histology. Spraying phages in the presence of chickens can be an option to lower infection 
pressure, although phages might have a narrow host range limiting their efficacy. Phages 
might be orally administered in feed in special polymer capsules (Stanford et al., 2010) or 
microspheres (Ma et al., 2008) that open and release their contents upon arrival in the 
intestine. In these capsules or microspheres phages are protected from the low pH in the 
proventriculus and gizzard, and can reach directly the reservoir of APEC. This has already 
been performed against E. coli O157:H7 in cattle and demonstrates that targeted bacteria are 
reduced after treatment (Sheng et al., 2006; Stanford et al., 2010). 
 
3. Use of bacteriophages to treat colibacillosis 
During the second part of the study we evaluated the use of a cocktail of lytic phages for the 
treatment of colibacillosis. First, we developed a bioluminescent APEC strain (CH2-lux; 
Chapter V), in order to be able to follow up prevention and treatment effects (with e.g. 
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vaccination and phages, respectively) on the course of an APEC infection ex vivo. 
Correlations were found between bacterial numbers in the heart, liver and lung of 
experimentally infected four-week-old chickens and the bioluminescence of the 
corresponding homogenized tissue. Possibly the luminescent strain can also be used for real-
time imaging of (young) experimentally infected chickens to monitor adhesion, 
internalization, organ localization, invasion and persistence of the strain in order to better 
understand pathogenesis of APEC. Together with sequencing our infecting strain (CH2) this 
can help in unraveling the pathogenesis of APEC, in order to develop targeted treatments in 
the battle against APEC. For example antivirulence therapy by inhibition of expression or 
regulation of virulence genes (Cegelski et al., 2008; Defoirdt, 2013). During our study with 
phages, we used the non-luminescent CH2 strain as four-week-old chickens are too big for in 
vivo monitoring of the luminescent strain. A phage cocktail composed of four phages, able to 
lyse the latter strain in vitro, was tested. These phages had a broad host range, good stability 
at 42ºC (core body temperature of a healthy chicken) and a low frequency of development of 
resistant APEC mutants. In vivo administration of the cocktail to experimentally infected 
chickens did, however, not result in a reduction in mortality or lesion scores in comparison to 
infected/non-treated control chickens (Chapter VI). These results confirm that even though 
many promising results have been found with phages as curative method for colibacillosis 
(Huff et al., 2004; Lau et al., 2010; Oliveira et al., 2010), good in vitro results do not always 
lead to successful phage therapy. Successful in vivo phage therapy depends on many 
parameters, such as method of application and dose and time of administration (Huff et al., 
2003b; Huff et al., 2013; Ryan et al., 2011). Mathematical models exist in which several 
phage-related factors are taken into account, such as time of administration, dose applied, 
clearance by the host immune system, phage insensitivity and development of resistant 
mutants in order to predict treatment outcomes (Cairns et al., 2009; Payne and Jansen, 2001). 
But as most of these parameter estimations are based on in vitro analysis they often do not 
give good in vivo predictions. Furthermore, in vivo behaviour of phages is dependent on many 
more factors that are hard to predict, such as the rate of phage translocation to the infection 
site and the spread throughout the body, hindered binding of phages to the host receptor and 
non-linear phage pharmacokinetics (Tsonos et al., 2014). Henry et al. (2013) showed 
promising results when he used a lung infection model in order to compare in vivo efficacy of 
phages with in vitro behaviour, based on real-time monitoring of the infection using 
bioluminescence. Further research on this model and development of other models for other 
pathogens might help in understanding in vivo behaviour of phages in order to reduce
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variability in treatment outcomes.  
However, infections that rapidly become systemic might not be treatable using phages. This 
might also be the case with our model strain CH2, since bacteria could already be observed in 
the blood of four-week-old chickens two h after intratracheal infection. Possibly, phage 
therapy efforts should then focus on prevention rather than treatment. 
An alternative to use life phages is to use phage endolysins. Endolysins hydrolyze the 
bacterium wall (peptidoglycan layer) from within the bacteria, so that phage progeny can be 
released. Up to now, no bacterial resistance towards lysins has been documented (Schmelcher 
et al., 2012), probably due to the binding and cleaving unique and essential targets in the cell 
wall (Fischetti, 2005; Fischetti, 2010). These enzymes are mostly used against Gram-positive 
bacteria, as the peptidoglycan layer of Gram-positive bacteria is in direct contact with the 
environment; several successful studies have already been described with Streptococcus 
pneumoniae in mice and rats (Grandgirard et al., 2008; Jado et al., 2003; Loeffler et al., 2003; 
Loeffler et al., 2001; Nelson et al., 2001). Gram-negative bacteria are different in that their 
peptidoglycan layer is protected by an outer membrane. Genetically engineering lysins by 
fusing bacterial cell wall adhesins to the catalytic domains of lysins and addition of outer 
membrane-permeabilizers should tackle this problem (Briers et al., 2011; Lai et al., 2011; 
Lukacik et al., 2012). Addition to the feed of chickens would be the most practical and 
economic feasible way of administrating the purified lysins. 
 
General conclusions 
Overall we can conclude that a more sensitive standardized method to determine the 
occurrence of resistance towards disinfectants is needed. Thereby disinfectants should also be 
tested under natural conditions in poultry houses, where also biofilms are present, in order to 
have a better idea on their actual efficacy. Even though we did not find positive results 
concerning in vivo phage therapy, it remains a valuable candidate in order to diminish 
antibiotic use (and thereby resistance selection). The focus should be on understanding the in 
vivo behaviour in order to diminish variability in treatment outcomes.  
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